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1 Abbreviations 
µg Microgram 
µl Microliter 
µM Micromol  
AP Alkaline phosphatase 
APC Adenomatous polyposis coli 
APC Fluorochrome APC, Alexa Fluor 647 
DMEM Dulbecco'‟s Modified Eagle Medium 
DPBS Dulbecco‟s Phosphate buffered Saline 
Dsh Dishevelled 
FBS Fetal bovine serum 
Fz or Fzd7 Frizzled 7 
GSK-3 Glycogen Synthase Kinase 3 
hESC Human embryonic stem cell 
HUES9 Human embryonic stem cells (9) 
iPSC Induced pluripotent stem cell 
IWP  Inhibitor of Wnt Production (= IWP-1) 
IWR  Inhibitor of Wnt Response (= IWR-1-exo) 
KMOS Klf4, c-Myc, Oct4, Sox2  
(4 Yamanaka factors) 
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KOS or w/o c-myc Klf4, Oct4, Sox2 
(3 Yamanaka factors) 
KSR Knock out serum 
MCM Condition media 
MEF Mouse embryonic fibroblasts 
NEAA Non-essential amino acid 
PEI Polyethyleneimine 
ROR2 Receptor tyrosine kinase-like orphan 
receptor 
Rpm Rounds per minute 
VPA Valproic Acid Salt 
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2 Introduction 
In the process of cellular differentiation an unspecialized cell becomes a more 
specialized cell type. Differentiation occurs multiple times during development of a 
multicellular organism. An undifferentiated cell which is able to divide and give rise to all 
cell types of an adult organism is known as pluripotent. In mammals, these pluripotent 
cells are called embryonic stem cells. Some years ago scientists wondered whether 
differentiation is terminal or can be reversed. This debate was put to rest when 
differentiated cells were reprogrammed to pluripotent cells. Several methods were 
established, some less or more efficient: 
2.1 Reprogramming of somatic cells:  
Recent breakthrough studies demonstrated that somatic cells can be reprogrammed to 
an embryonic stem cell-like, or induced pluripotent stem cell (iPSC) state (Yamanaka et 
al. 2006). This technology holds great promise for development of patient-specific cell 
populations suitable for cell replacement therapies. Reprogramming of somatic cells 
opened a broad field of scientific research and eliminated many of the ethical issues 
associated with embryonic stem cells.  
There are several different methods to reprogram a somatic cell. The first and most 
useable methods are cell fusion, somatic nuclear cell transfer (SNCT) and the most 
common method for iPSC generation, the transduction of a defined set of transcription 
factors in somatic cells (King and Briggs 1953; Yamanaka et al. 2006 and Yu et al. 
2007) 
2.1.1 Somatic nuclear cell transfer (SNCT): 
Somatic nuclear cell transfer is a laboratory technique to create a clonal embryo using 
an enucleated oocyte and a diploid donor nucleus. This technique is used in embryonic 
stem cell research and regenerative medicine referred to as therapeutic cloning. The 
donor nucleus of a somatic cell is removed and then inserted into a denucleated oocyte. 
The first example of a cloned model organism, the northern leopard frog, was by King 
and Briggs (King and Briggs 1953). They described the method of transferring a nucleus 
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from an embryonic cell into an enucleated and unfertilized egg of the same species 
(Rana pipiens). A couple of years later Gurdon (Gurdon JB et al. 1958) extended this 
postulate by cloning Xenopus laevis and modifying the technique. More recently, this 
technique of SCNT has been used to clone many other animals, including the sheep 
named Dolly (Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH (1997). "Viable 
offspring derived from fetal and adult mammalian cells". Nature 385 (6619): 810–3). 
2.1.2 Breakthrough -  Generation of induced pluripotent stem cells by Yamanaka: 
Induced pluripotent stem (iPS) cells can be created by reprogramming somatic cells 
with retroviral transduction of four transcription factors Oct4, Sox2, Klf4, and c-myc 
(Yamanaka et al. 2006) or Oct4, Sox2, Nanog and Lin28 (Yu et al. 2007).  
Yamanaka selected 24 genes as candidate factors for iPSC generation (Figure 1) by 
narrowing them down to 10 and finally to the 4 genes listed above. It turned out, that the 
4 factor transduction showed the most colonies and the best colony formation. 
(Yamanaka et al. 2006) 
 
Figure 1: Effect of the removal of individual factors from the pool of 24 transduced factors  
(Yamanaka et al. 2006), marked are the 10 factors, which were used for further investigations. 
Rectangles: 4 factors, essentially used for general iPSC generation (Oct4, Sox2, Klf4, c-Myc); Circles: 6 
factors which were in the short list, including β-catenin. 
 
These iPS cells are thought to hold therapeutic potential, as somatic cells (mouse 
embryonic fibroblasts, MEF and adult mouse tail tip Fibroblasts, TTF) from an individual 
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could be reprogrammed and utilized to generate patient-specific cell types suitable for 
transplantation. For instance, it has been postulated that iPSC technology could be 
used to produce tissue for patients with retinal degeneration (Comyn et al. 2010). 
However, current methods of reprogramming require integration of retroviruses, which 
have been demonstrated to increase the risk of tumorigenesis (Okita et al. 2007). These 
methods suffer from the burden to potentially alter the recipient genome by gene 
insertion (Ho et al. 2010). However, depending on the cell type to be reprogrammed, 
some of these factors can be eliminated or replaced with small molecules. These 
alternative methods of generating iPS cells, without modifying the genome need to be 
established in order to improve the prospect of therapeutic applications of iPS cells, for 
instance protein-mediated (Kim et al. 2009) or RNA-mediated iPS cell production 
(Warren et al. 2010). A potential alternative method to achieve the iPS cell state is 
through manipulation of the culture conditions, or the extracellular microenvironment. 
Many developmental studies have demonstrated that differentiation and regenerative 
processes are regulated by multiple developmental signaling pathways. One such 
developmental signaling pathway is regulated by Wnt genes.  
 
2.1.3 Method of reprogramming – Retroviral transduction: 
This method was established by Yamanaka et al. 2006 and is described extensively in 
chapter 3.2.1.4 and the used materials in chapter 3.1.3. 
First the transfection or virus production was performed. The retrovirus of 4 factors 
(Oct4, Klf4, Sox2 and c-Myc) was produced on HEK 293T cells, which are easy to 
handle and transfect. To get a high titer virus, it was recommended, to transfect several 
plates per vector. Each factor had a packaging (CMV-GP) and an envelope plasmid 
(VSVG, see Table 27). After transfecting 5-6 hours with transfection reagent PEI, the 
media was changed and the 72 hour transfection for virus collection was started. After 
the condition media was collected, the virus purification was started by centrifugation 
with an ultracentrifuge. The virus pellet was resuspended over night and used for 
transduction on the next day. 
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Second of all, the transduction into somatic cells or also virus infection was 
accomplished. The concentrated virus was used to infect adult human foreskin 
fibroblasts to be reprogrammed. The small amount of virus (usually around 200µl) was 
added to the normal culture media of fibroblasts and changed after 5-6 hours infection. 
Between 8 and 12 days post-transduction induced pluripotent stem cell colonies 
emerge. 
 
2.2 Consideration of Wnt signaling in reprogramming process  
Currently, 19 distinct WNT (Wingless and INT-1) genes have been identified that code 
for secreted lipid-modified glycoproteins (see the “Wnt homepage” at 
http://www.stanford.edu/group/nusselab/cgi-bin/wnt/; Nusse et al.2009). Wnt signaling is 
involved in embryonic development and is required for tissue homeostasis of adult 
organs (Clevers et al. 2006). Germline mutations in the Wnt pathway cause several 
hereditary diseases, and somatic mutations are associated with cancer of the intestine 
and a variety of other tissues (Clevers et al. 2006). 
Mutations in WNT genes or disruptions in the Wnt signaling pathway can 
catastrophically alter human embryonic development (Logan et al. 2004) and can 
contribute to disease, most notably cancer (Clevers et al. 2006, Kinzler et al. 1996, 
Klaus et al. 2008). For example loss of WNT3 function has been shown to lead to tetra-
amelia, a rare and fatal genetic defect (Niemann et al. 2004). Additionally, the Wnt 
signaling cascade has been demonstrated to exert significant effects on adult stem cells 
of the intestine (Gregorieff et al. 2005), skin (Gat et al. 1998, Ito et al. 2007), brain 
(Chenn et al. 2002, Kalani et al. 2008, Lie et al. 2005, Soen et al. 2006) and blood 
(Reya et al. 2003, Willert et al.2003, Luis et al.2009).  
More recent studies also suggest that Wnt signaling influences the efficiency of 
induction of the pluripotent state, even in the absence of c-Myc (Marson et al. 2008). 
This raises the possibility of manipulating Wnt signaling as a means of inducing 
pluripotency without the use of viral transduction of transcription factor genes, which 
carry the risk of oncogenic mutations. 
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Several lines of evidence indicate that Wnt signalling affects iPSC generation 
(Yamanaka et al. 2006, Marson et al. 2008). However, it is not known whether Wnt 
signaling is essential to the reprogramming process. β-Catenin was one of the 24 genes 
which were used as candidate factors (Figure 1). As far back as Yamanaka‟s 
breakthrough, he showed the importance of β-catenin and the Wnt pathway involvement 
in iPSC generation. 
 
The role of β-catenin in Wnt signaling is indispensable. Wnt/β-catenin signaling is called 
„The Canonical Wnt Signaling Pathway‟ (Figure 2). In the absence of Wnt signaling, 
Glycogen synthase kinase (GSK-3) constitutively phosphorylates the β-catenin protein. 
β-catenin is associated with Axin, a scaffold-protein, complexed with GSK-3 and 
adenomatosis polyposis coli (APC). Phosphorylated β-catenin is subsequently 
degraded,so that its steady state levels are low. Wnt signaling is initiated when Wnt 
binds its receptor, frizzled (Fz), and dishevelled (Dsh/Dvl) is recruited to the membrane. 
GSK-3 is inhibited by the activation of Dvl. Accordingly, β-catenin accumulates and can 
be subsequently translocated into the nucleus where Wnt target genes are activated 
(Figure 2). Thus β-catenin functions as key component in canonical Wnt signaling. 
Additionally, β-catenin is also part of the complex which forms adherens junctions for 
cell-cell-adhesion. 
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Figure 2: Canonical Wnt Signaling (Reya et al. 2005) 
 
2.3 Use of Wnt signaling pathway inhibitors 
Wnt signaling proteins are small secreted proteins that are active in embryonic 
development, tissue homeostasis, and tumorigenesis. Wnt proteins bind to receptors on 
the cell surface, initiating a signaling cascade that leads to β-catenin activation of gene 
transcription. Chen B. et al. 2009 identified two classes of small molecules that disrupt 
Wnt pathway responses. Whereas one class inhibits the activity of porcupine the other 
abrogates destruction of Axin proteins suppressors of the Wnt pathway activity. 
 The first class is IWP compounds, which are inhibitors of Wnt production. IWP 
compounds target the acyltransferase porcupine and inactivate it. Porcupine is a 
member of the membrane-bound O-acyltransferase (MBOAT) family and usually adds a 
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palmitoyl group to Wnt proteins that is essential for the production of Wnt proteins and 
their signaling ability. IWP action is that it inactivates Porcupine function, either by 
directly inhibiting the porcupine or a porcupine regulator. 
 The second class is IWR compounds, which are inhibitors of Wnt response. Through 
the addition of IWR compounds, Axin protein levels rise, accompanied by elevated 
levels of β-catenin phosphorylation which lead to a proteasome-mediated destruction of 
β-catenin. IWR compounds induce stabilization of Axin proteins via direct interaction 
that could be used to control levels of Wnt pathway response. 
 
Another suppressor is GSK3-inhibitor (factor XV) which is a highly bioreactive complex 
that acts as an inhibitor by binding to the ATP binding site through an induced fit 
mechanism. In addition this complex induces the Wnt signaling pathway in mammalian 
cells. 
2.4 Objectives of my work 
The goal of this project is to study the influence of Wnt signaling on the regulation of 
induced pluripotency. We hypothesize that Wnt signaling is a necessary component of 
the reprogramming process capable of inducing and maintaining the pluripotent state. 
The results of this project should provide significant insight into the possibility of utilizing 
Wnt proteins as reagents to generate and maintain iPS cells. We will perform standard 
reprogramming of human fibroblasts using this method while perturbing Wnt signaling in 
a number of ways. The used modulators are IWP-1, IWR-1-exo, GSK3-inhibitor (factor 
XV), Wnt3a and Wnt5a. IWP-1 and IWR-1-exo should suppress Wnt signaling (see 
chapter 2.3). GSK3-inhibitor inhibits Wnt signaling in a double negative way; therefore 
Wnt signaling will be activated. Wnt3a activates the canonical pathway and Wnt5a 
activates the non-canonical one but inhibits the canonical Wnt signaling. Axin and β-
catenin are two genes, which will be overexpressed, and Frizzled 7 and Receptor 
tyrosine kinase-like orphan receptor (ROR2) knocked down. Adult human foreskin 
fibroblasts were used as somatic cells for the reprogramming process. For further used 
cell types see chapter 3.1.2. 
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A long-term goal of our studies is to generate iPS cells with soluble factors, including 
Wnt proteins, rather than the four retroviral factors, which need to be transduced into 
the cells, thereby permanently and potentially adversely altering the genomic make-up 
of the reprogrammed cell.  
We established the basic methodology for generating iPS cells using the factors from 
the Yamanaka laboratory (Yamanaka et al. 2006, Takahashi et al. 2007). Willert‟s lab 
studies the role of Wnt signaling in embryonic stem cells and this project on iPS cell 
generation is a natural extension of this work. 
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3 Materials and Methods 
3.1 Materials: 
3.1.1 Equipment: 
Table 1: Used equipment 
device 
 
device name supplier 
Beckman centrifuge tube Cat.nr. 358126 Beckman 
cell culture plates 
(15cm,10cm,6-well, 12-
well) 
 Coring 
cell Strainer (40µm)  BD Falcon 
Cellomics microarray 
 
Cellomics VTI High Content 
Screening System 
Thermo Fisher Scientific 
Inc. 
centrifuge 5810R 15amp version Eppendorf 
centrifuge Avanti J-E Centrifuge Beckman Coulter 
conical tubes (15ml, 50ml)  Sarstedt, Corning 
cryo 1°C mMr. Frosty 
freezing container with 
isopropanol  
 NUNC 
 
cryo-vials  Nunc 
EVOS dissection 
micorscope 
EVOS AMG 
FACS tube  BD Falcon 
flow cytometer BD FACSCanto II BD Biosciences 
freezer -20°C  Kenmore 
freezer -80°C/-150°C  Sanyo- VIP Series 
fridge 4°C  Sanyo 
gelelectrophoresis device  Biorad 
gene pulser cuvette (0.2cm)  Biorad 
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genepulser  Biorad 
imager (gels, plates)  Alpha Innotech 
incubator Sanyo Co2 Incubator Sanyo Scientific 
incubator shaker Max-4000, A-Class Barnstead-Lab Line 
isopropanol  Sigma Aldrich 
maxiprep kit NucleoBond  Macherey-Nagel 
microscope Axiovert 40, CFL Zeiss 
nanospectrometer ND-1000 Nanodrop 
PCR machine  Eppendorf 
qPCR machine 7900 HT Fast Real-Time 
PCR System 
Applied Biosciences 
qPCR plate  Sigma Aldrich 
RNA isolation Kit NucleoSpin RNA II Macherey-Nagel 
scale S-4001 Denver Instrument 
sterile filter (0.22µm)  Millipore 
sterile one-way pipettes  Costar 
syringe Luer-Lok Tip  
(5ml, 10ml) 
 BD Falcon 
tissue culture hoods Class II Biohazard Safety 
Cabinet 
ESCO 
ultracentrifuge Optima L-80 XP 
Ultracentrifuge 
Beckman Coulter 
waterbath Aquabath Barnstead-Lab Line 
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3.1.2 Cell types 
 Human embryonic Kidney (HEK) 293T Cells: (America Type Culture Collection - 
http://www.atcc.org). HEK 293T cells are easy to culture and transfect. The 
transfectability by various techniques is about 100% and they have a high expansion 
rate. 
In my work, these cells were used for lentiviral and retroviral production. 
 
 Primary mouse embryonic fibroblasts: Millipore-Speciality Media, Embryomax ® 
PMEF-P3, Strain CF-1, Cat# PMEF-CF, Lot# 90927-4, Store -80°C 00004)  
PMEF feeders are treated with mitomycin-C and can be directly plated. These cells 
are from passage 3. 5-6 x 106 cells will produce the appropriate density feeder layer. 
 
In my iPSC protocol a monolayer of primary mouse embryo fibroblast (PMEF or 
MEF) was used as feeder cells. They perform two important roles in stem cell 
culture: they secrete several important growth factors into the medium, which help 
maintain pluripotency, and they provide a cellular matrix for iPS cells to grow. 
 
 Adult human foreskin Fibroblasts (WT83) 
Cassiano Carromeu from the Muotri Lab at UCSD established this cell line. The cell 
line has a low passage number and its abbreviation is WT83. 
 
 Human embryonic stem cells:  
The human embryonic stem cell lines are pluripotent and were previously derived 
from human blastocysts (Cowan et al N Engl J Med. 2004 Mar 25;350(13):1353-6; 
Thomson et al. Science. 1998 Nov 6;282(5391):1145-7). 
In my work I used the HUES9 (Harvard University, HUES cell facility) line mainly as 
positive control for pluripotency. Pluripotency antibody markers are SSEA-3, SSEA-
4, Tra 1-60, Tra 1-81, Oct-4 and staining for alkaline phosphatase. 
 (http://www.mcb.harvard.edu/melton/HuES/, http://stemcells.nih.gov) 
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3.1.3 Materials for cell culture 
3.1.3.1 Reagents, chemicals, small molecules, buffers: 
Table 2: List of reagents, chemicals, small molecules and buffers used for cell culture 
product supplier 
2-mercaptoethanol (55µM final) 55mM stock  GIBCO-Invitrogen 
Accutase Millipore 
bFGF, stock: 100ng/µl Millipore 
Collagenase GIBCO-Invitrogen 
DMEM (different types) Cellgro 
DMSO  Sigma Aldrich 
FBS (fetal bovine serum) GIBCO-Invitrogen 
Gluta-MAX GIBCO-Invitrogen 
GSK3-inhibitor (Factor XV) 10mM Calbiochem;  
EMD4 Biosciences Santa Cruz 
HY Clone-DPBS/Modified Thermo Scientific 
IWP; Inhibitor of Porcupine (IWP-1) 5mM Lawrence Lum lab; 
University of Texas, Southwestern 
Medical Center Dallas 
IWR; Inhibitor of Axin (IWR-1-exo) 10mM Lawrence Lum lab; 
University of Texas, Southwestern 
Medical Center Dallas 
Knock out serum (KSR) GIBCO-Invitrogen 
Matrigel BD 
NEAA Cellgro 
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Penicillin/Streptomycin GIBCO-Invitrogen 
Plasmanate  Talecris Biotherapeutics 
TrypLETM Express  GIBCO-Invitrogen 
Valproic acid sodium salt (VPA) 10mM 
dissolved in DPBS 
Sigma Aldrich 
WNT protein buffer: 1%CHAPS, 1x PBS, 1M 
NaCl  
CHAPS  
3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonate 
1%CHAPS, 1x PBS, 1M NaCl; various 
vendors; e.g. BIOTANG 
Wnt3a, stock: 2.5µM Willert lab; UCSD 
Wnt5a, stock: 2.5µM Willert lab; UCSD 
 
3.1.3.2 Growth Media: 
Table 3: Composition of growth media for 293T cell culture, foreskin fibroblast cell culture and MEF cells 
culture. 
Ingredient Amount (specifications for 550ml-560ml) 
DMEM 1x 500ml 
FBS (10%) 50ml 
Penicillin/Streptomycin (1%)  (optional) 5ml 
Glutamine (optional) 5ml 
 
Table 4: Composition of growth media for 293T cell culture used after transfection 
Ingredient/supplier Amount (specifications for 520ml-530ml) 
DMEM 1x  500ml 
FBS (4%) 20ml 
Penicillin/Streptomycin (1%)  (optional) 5ml 
Glutamine (1%) (optional) 5ml 
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Table 5: Composition of growth media for human embryonic stem cell (HUES9) culture. 
Ingredient /supplier Amount (specifications for 500ml) 
Knockout DMEM 385ml 
Knockout Serum 50ml 
Plasmanate 50ml 
NEAA 5ml 
Penicillin/Streptomycin  5ml 
Gluta-MAX 5ml 
2-mercaptoethanol (55µM final) 55mM 
stock  
0.5ml 
HESCs (HUES9) require bFGF for undifferentiated growth. For best results it is 
recommended to add bFGF immediately prior to use (final concentration of 20ng/ml) 
Table 6: Composition of growth media for induced pluripotent stem cell generation. 
Ingredient/supplier  Amount (specifications for 200ml) 
DMEM/F-12,50/50, 1x  158ml 
Knockout Serum  40ml 
NEAA 2ml 
2-mercaptoethanol (55µM final) 55mM 
stock 
0.4ml 
 
Table 7: Composition of freezing media. 
Ingredient/supplier Amount (specifications for 50ml) 
DMSO (10%) 5ml 
FBS (90%) 45ml 
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3.1.4 Materials for microbiological methods 
3.1.4.1 Microorganisms:  
E.Coli DH5α cloning strain was used for all transformations. The bacteria were 
transformed with high efficiency. Successful DNA transformation was ensured by 
antibiotic selection. All plasmids carried the gene that confers ampicillin resistance. 
3.1.4.2 Growth media: 
Table 8: Chemical composition of Terrific Broth (Mediatech-VWR-Cellgro). 
ingredient amount (specifications for 1000ml) 
Casein Peptone 12 g 
KH2PO4 2.31g 
K2HPO4 12.54g 
UF Yeast Powder 24 
Glycerol 4ml 
 
Table 9: Chemical composition of Miller‟s Luria Batani (LB) Broth (Mediatech,Inc)). 
ingredient amount (specifications for 1000ml) 
Casein Peptone 10g 
NaCl 10g 
UF yeast powder 5g 
 
3.1.4.3 DNA-plasmids: 
Table 10: List of DNA plasmids used for retroviral production of the four Yamanaka factors 
(www.addgene.org) 
name (retroviral) concentration ng/µl ratio 260/280 
pMX-hc-Myc 2513.10 1.88 
pMX-hKlf4 2853.21 1.86 
pMX-hSox2 3548.31 1.85 
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pMX-hOct4 3468.25 1.85 
CMV-GP (packaging vector) 1928.67 1.89 
VSVG (envelope vector) 4910.81 1.57 
 
 
Table 11: List of DNA plasmid constructs used for lentiviral production to knockout or overexpress Wnt 
pathway compounds (www.addgene.org) 
name (lentiviral) concentration ng/µl ratio 260/280 
β-catenin-HIV-IRE 4059.48 1.79 
Axin-HIV-IRE 1631.02 1.84 
Fzd7(5)shRNA 4684.21 1.67 
ROR2shRNA-625 2972.04 1.86 
ROR2shRNA- 1490 2196.50 1.88 
Lentiviral GFP reporter 1494.86 1.89 
psPAX2 (packaging vector) 3554.25 1.84 
VSVG (envelope vector) 4536.86 1.71 
 
Table 12: Concentration and pH of the retroviral and lentiviral transfection reagent polyethyleneimine  
(PEI ) 
PEI concentration: 1µg/µl  1 x PBS pH 4.45 
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3.1.5 Materials for molecular biological methods 
3.1.5.1 Kits 
Table 13: List of kits used for molecular biological methods. 
Product cat. no. Supplier 
RNA isolation  740955 Nucleospin RNAII; 
Macherey-Nagel 
Plasmid DNA Purification 
(Maxiprep) 
12162 
740414 
 Qiagen 
 NucleoBond; 
Macherey-Nagel 
Alkaline Phosphatase (AP) 
Staining Kit 
000009 StemGent 
 
3.1.5.2 Buffers 
Table 14: List of buffers used for molecular biological methods. 
Product supplier 
DPBS Mediatech 
50x TAE Buffer  
(Tris Base, Acetic acid, EDTA)  
242g TrisBase, 57.1ml glacial acetic acid, 
18,6g EDTA for 1000ml 
 
Table 15: Buffers and reagents for Maxiprep (NucleoBond; Macherey-Nagel) 
product amount 
Buffer RES 150ml 
Buffer LYS 150ml 
Buffer NEU 150ml 
Buffer EQU 500ml 
Buffer WASH 300ml 
Buffer ELU 180ml 
Rnase A (lyophilized)* 10mg 
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70% Ethanol (Sigma-Aldrich) 50ml 
Isopropanol (Sigma-Aldrich) 50ml 
1x TE-Buffer (pH: 8.0) 50ml 
* Rnase A was dissolved by the addition 1ml buffer RES. After dissolving, the Rnase A 
solution was transferred back to the bottle containing buffer RES. The buffers final 
concentration of Rnase A is 60µg/ml. 
 
Table 16: Buffers and reagents for RNA isolation (Nucleospin RNAII; Macherey-Nagel) 
product amount 
Lysis Buffer RA1 25ml 
Wash Buffer RA2 15ml 
Wash Buffer RA3 12.5ml 
Membrane Desalting Buffer (MDB) 25ml 
Reaction Buffer for rDNase 7ml 
rDNase (Rnase-free, lyophilized)* 1 vial 
Rnase-free H2O 15ml 
2-Mercaptoethanol (GIBCO) 50ml 
70% Ethanol (Sigma Aldrich) 50ml 
*540µl of Rnase-free H2O was added to the rDNase vial and incubated for 1 minute at 
room-temperature. The Dnase was completely dissolved and aliquoted 10µl per tube for 
storage at -20°C. 
 
3.1.5.3 Reagents, chemical, primers and enzymes: 
Table 17: List of reagents and chemicals used for molecular biological methods 
product supplier 
UltraPure Agarose Invitrogen 
1kbDNA ladder O‟GeneRuler  
0.1µg/ml 
Fermentas 
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6x Loading dye Fermentas 
Sybr Safe DNA gel stain  
(10,000x concentration in DMSO) 
Invitrogen 
qScript cDNA Supermix Quanta; Biosciences Inc. 
TaqMan ® Mastermix  Gene Expression Assays – Applied 
Biosciences 
TaqMan ® Probes (18S, Nanog, Pou5F1) Gene Expression Assays – Applied 
Biosciences 
 
Table 18: List of primer sequences used for molecular biological methods to verify pluripotency of 
established iPS cell lines 
name sequence 
Nanog TCACACGGAGACTGTCTCTCCTCTT 
Pou5f1 GTGAATGACATTTGTGGGTAGGTTA 
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Table 19: List of restriction endonucleases and restriction endonuclease buffers (www.neb.com) to verify 
the purified plasmids 
restriction enzymes & buffers supplier 
EcoRI (NEB3 or EcoRI buffer) 20U/µl New England Biolabs (NEB) 
XhoI (NEB4) 20U/µl New England Biolabs (NEB) 
NotI (NEB3)10U/µl New England Biolabs (NEB) 
PvuII (NEB2) 10U/µl New England Biolabs (NEB) 
HindIII (NEB2) 10U/µl New England Biolabs (NEB) 
10x NEBuffer 2, 100x BSA New England Biolabs (NEB) 
10x NEBuffer 3, 100x BSA New England Biolabs (NEB) 
10x NEBuffer 4, 100x BSA New England Biolabs (NEB) 
10x EcoRI buffer , 100x BSA New England Biolabs (NEB) 
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3.1.6 Materials for analytical methods 
3.1.6.1 Chemicals, buffers, reagents 
Table 20: List of chemicals used for analytical methods 
product supplier 
Trypan Blue Stain 0.4% Gibco-Invitrogen 
Albumin from bovine serum (BSA) Sigma 
DAPI Sigma Aldrich 
Glycine Solution (2.6M) in PBS J.T. Baker 
 
Table 21: Chemical composition of flow cytometry buffer (FACS-Buffer) 
ingredients amount (specifications for 510ml) 
DPBS 500ml 
BSA (1%) 0.5g 
EDTA (10mM) 10ml of 0.5M EDTA 
 
3.1.6.2 Antibodies 
Table 22: List of antibodies used for analytical methods 
product supplier 
Alexa Fluor 647 mouse anti-human Tra1-81 IgM (conjugated) 
5µl/1million cells 
Biolegend 
Isotype Control: Alexa Fluor 647 mouse IgM,ĸ 
5µl/1million cells 
Biolegend 
PE mouse anti-human SSEA-4  
(MC-813-70  Ig G3 (conjugated) 
5µl/1million cells 
Biolegend 
Isotype Control PE mouse Ig G3, ĸ Biolegend 
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3.1.6.3 Alkaline phosphatase staining kit (StemGent) 
Table 23: Alkaline phosphatase staining kit used for iPSC generation quantification 
product amount  
PBST (0.05% Tween) 500ml 
Fix Solution 25ml 
Solution A 10ml 
Solution B 10ml 
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3.1.7 Software programs for bioinformatic methods 
Table 24: Software programs and databases used for bioinformatic methods 
software 
program/database 
supplier/website 
Addgene http://ww.addgene.org  
Pubmed http://www.ncbi.nlm.nih.gov/pubmed  
National Center for 
Biotechnological Information 
http://www.ncbi.nlm.nih.gov/  
Cell culture information http://www.tpp.ch/technical_information/product_informati
on/Cell_cultivation.htm 
Flow Jo http://www.flowjo.com/  
Cellomics Software 
(data not shown) 
http://www.cellomics.com  
ArrayScan® VTI (500 Series)Version 5.1.10-0.63x (Build 
6027)  
Microsoft Office http://office.microsoft.com/  
Photoshop CS5 http://www.photoshop.com  
The Global Bioresource 
Center 
http://www.atcc.org 
HUES Cell Collection http://www.mcb.harvard.edu/melton/HuES/ 
Stem Cell Information http://stemcells.nih.gov 
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3.2 Methods: 
3.2.1 Cell culture methods 
3.2.1.1 General procedures: 
All cell culturing was performed in the UCSD Human Embryonic Stem Cell Core Facility, 
under sterile conditions, using the Class II Biohazard Cabinet, unless otherwise stated. 
Sterile one way materials were used. Lab coats and gloves were always worn. Media or 
other reagents were warmed up to 37°C and hands were washed with 70% ethanol 
before working or touching cell dishes. Cells were cultured on 15cm, 10cm or 6-well 
plates and stored at 37°C with 5% CO2. The cell confluency was checked under the 
light microscope (Zeiss) 
Table 25: List of reagent volumes according to dish sizes 
dish size growth media vol. DPSB vol. dissociation vol. bFGF vol. 
15cm dish 20ml 15ml TrypLE 3ml 5µl 
10cm dish 10ml 10ml Accutase 3ml, 
TrypLE 2ml 
3µl 
6-well 3ml 3ml TrypLE 1ml, 
Collagenase 1ml 
1µl 
12-well 1.5ml 1.5ml Tryple 0.5ml 0.5µl 
 
3.2.1.2 Culture of HEK 293T cells 
HEK 293T cells were always cultured in a 15cm plate with DMEM 1x + 
10%FBS, except for production of retro- or lentivirus when DMEM 1x + 4% FBS 
was used. 
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 Cell thawing: 
A vial of cells was thawed in the waterbath at 37°C. 9ml of pre-warmed media 
were added to a 10cm dish, and after entirely thawing the cell suspension, cells 
were spread evenly over the plate and gently mixed. 
 
 Cell passaging: 
Cells were washed gently with DPBS and TrypLE was added (amounts of 
reagents to their according dish size, see Table 25). The plate was incubated at 
37°C for 5 minutes. The dissociated cells were easily removed by adding Media. 
For better dispersion, the cell suspension was 27ignali up and down 5 times. 
Depending on the requested density, the appropriate amount of cell suspension 
was transferred into the next culturing plate and gently mixed to spread them out. 
Usually cells were split 1:5 every other day. 
 
 Cell freezing: 
Until cell dissociation the procedure was done as already described in chapter 
3.2.1.2–cell passaging. Afterwards the cell suspension was transferred into a 
15ml conical tube and centrifuged at 200 x g for 4 minutes. The liquid was 
aspirated and the cell pellet was resuspended in 1ml freezing media per 12-16 x 
106 cells (Table 28). The cells were transferred immediately into a cryo-tube, 
inserted into a Mr. Frosty (Nalgene Labware) containing Isopropanol. Mr. Frosty 
was stored at -80°C overnight allowing the cells to slowly freeze (approximately 
1°C decrease per minute). After one day at -80°C the tubes can be transferred 
into the -150°C freezer. 
 
3.2.1.3 Transfection for lentivirus (2nd Generation): 
Transfection 
Lentivirus was always produced by transfecting HEK 293T cells. The cell dish was 70% 
confluent, or ~11 x 106 cells per 15cm dish. To increase the amount of virus it was 
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recommended to transfect at least two plates per virus.  Specific amounts of DNA were 
used (see Table 26). 
 
Table 26: Amount of plasmid DNA for lentiviral transfection in one 15cm plate 
vector amount (µg) molar ratio size (kb) 
Transfer vector 22.5 2 8-9 
psPAX2 14.6 1 10.7 
VSVG 7.9 1 5.8 
 
The plasmid mix (see Table 26) was added to 1ml of DMEM 1x, filtered, and 4 times the 
amount of DNA, of PEI (1µg/µl) was added. The tube was vortexed and incubated for 5 
minutes until PEI neutralized the anionic colloidal charge. The 1ml was spread out over 
the plate. Mixed briefly and incubated at 37°C at 5% CO2. The media was changed 5-6 
hours post-transfection. 
Virus collection: 
The first virus collection was performed 48 hours post-transfection. The supernatant 
was filtered (0.22µm filter unit) and stored at 4°C. 72 hours post-transfection, a second 
media collection was done. First and second virus collections were pooled and 
processed as follows.  
Virus purification: 
For purifying the virus, the Beckman Coulter Optima L-80 XP Ultracentrifuge with the 
SW 32 Ti rotor was used, which fits 6 centrifuge capsules. Before loading the virus, the 
capsule was placed into a tube holder on a laboratory scale. An adapter and the 
Beckman centrifuge tube were inserted and the scale was tared. The ultracentrifuge 
requires that all samples are perfectly balanced against each other. The amount of 28g 
of liquid virus was not exceeded and the two capsules towards each other were 
supposed to have a difference not more than 0.05g. If compensation was needed in any 
tube, DMEM F-12 was added. 
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If the tubes were not filled with the correct amount of liquid, they would have collapsed 
during centrifugation. These special tubes need an adapter to properly fit in the 
capsules.  
After loading virus and capsules, the ultracentrifuge was set up at 19400 rpm and 4°C. 
Two hours later the centrifuge tubes were carefully removed from the capsules. On the 
bottom of the tube a small pellet should be visible. The supernatant was discarded into 
10% bleach and the centrifuge tubes inserted into 50ml conical tubes. 100µl of DMEM-
High Glucose was added onto the cell pellet and not-mechanically resuspended over 
night at 4°C. On the next day fibroblasts were infected with 150-200µl of virus. (see 
chapter 3.2.1.10) 
3.2.1.4 Transfection for retrovirus: Yamanaka cocktail (Oct4, Sox2, Klf4, c-Myc) 
The method for generating iPS cells has been described (Yamanaka et al. 2006, see 
chapter 2.1.2). In this thesis the factors to induce the pluripotent state are called 
“Yamanaka factors”, “four factors” or “KMOS”, the abbreviation for Oct4, Sox2, Klf4, c-
Myc. 
The retrovirus was produced on HEK 293T cells as well. The cell dish was 80-100% 
confluent, or 16 x 106 – 20 x 106 cells per 15cm dish. To achieve a high titer virus, it was 
recommended to transfect at least 6 plates per vector. To generate all four viruses 
carrying the Yamanaka factors 24 plates were used. For specific amounts of transfected 
DNA, see table 27. 
Table 27: Amount of plasmid DNA for retroviral transfection in one 15cm plate 
vector amount (µg) size (kb) 
Transfer vector (factor) 13.8 5.5-6 
CMV-GP 9.2 ∼12 
VSVG 4.6 5.8 
 
The DNA-mix (see Table 27) was added to 1ml of DMEM 1x, filtered and 4 times the 
amount of DNA, of PEI (1µg/µl) was added. The tube was vortexed and incubated for 5 
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minutes until PEI neutralized the anionic colloidal charge. The 1ml was spread out over 
the plate. Mixed briefly and incubated at 37°C at 5% CO2. 5-6 hours post-transfection 
the media was replaced to 16ml DMEM 1x with 4% FBS to avoid cell overgrowth.  
 
Virus collection: 
The supernatant was collected only once after 72 hours post-transfection and all factors 
were pooled to simplify the virus purification. The virus collection was performed as 
already described in chapter 3.2.1.3. 
 
Virus purification: 
To harvest the virus, the description in chapter 3.2.1.3 was followed. Usually two 
centrifugations were set up for 24 plates containing 16ml of virus. 
On the next day, the virus was pooled, pelleted at 200 x g for 4 minutes and one 6-well 
of fibroblasts was infected with concentrated 200µl of virus-supernatant. 
 
3.2.1.5 Transfection for retrovirus: 3 Yamanaka factors without c-Myc (Oct4, Sox2, 
Klf4) 
The Yamanaka factors without c-Myc are called “three factors” or “KOS”, the 
abbreviation for Oct4, Klf4, Sox2. 
To set up a 3 factor retrovirus, 18 plates were used and the virus production was 
performed as described in chapter 3.2.1.4 without transfection of the transfer vector c-
myc. 
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3.2.1.6 Culture of adult human foreskin fibroblasts 
Early passage human foreskin fibroblasts were cultured in 10 cm dishes using DMEM 
1x + 10%FBS. 
 Cell thawing, passaging, freezing: 
The thawing, passaging and freezing procedures of human foreskin fibroblasts 
were done as already described in chapter 3.2.1.2 using the right amount of 
volumes (Table 25) fibroblasts needed longer for their dissociation and 
additionally could be used a cell scraper to completely detach all cells. 
3.2.1.7 Culture of MEFs 
Mouse embryonic fibroblasts (MEFs) were always cultured in DMEM 1x with 10% FBS. 
This cell type was previously mitotically inactivated by radiation. As a result MEFs were 
never passaged. After thawing, the cells were useable for up to one week. 
 Cell thawing and preparation of MEF plates: 
One vial of MEFs was used for eight 10cm dishes or other plate sizes with equal 
surface size. 
The thawing procedure of mouse embryonic fibroblasts was done as already 
described in chapter 3.2.1.2 using the right amount of volumes (Table 25). 
 
o MEF plates used for condition media (MCM): 
A day after preparing MEF plates (10cm) the media was changed to 15ml 
of HUES9 or iPSC media (see chapters 3.2.1.8 and 0). This step was 
performed every 24 hours for 7 days, and the condition media was 
collected by filtering. The MCM was useable for two weeks. 
 
o MEF plates used for feeder cells: 
Depending on the experiment, the size of dishes was chosen. For iPSC 
generation MEF cells were prepared on 6-well plates, one day before 
transferring other cells onto feeders. 
 
32 
 
3.2.1.8 Culture of HUES9  
HUES9 cells were always cultured on MEF plates or matrigel-coated plates. 
 Preparation of matrigel plates: 
A vial of matrigel (BD) was thawed on ice for 30 minutes and resuspended in 
25ml of DMEM-F12. The right amount of matrigel suspension was added to 
cover the plate, followed by 15 minutes incubation at 37°C. During the incubation 
time, the matrigel proteins were self-assembling, producing a thin film which 
covered the surface of the cell dish. After incubation the plates could be used 
immediately or stored at 4°C. 
 
 Production of HUES MCM: 
HUES MCM was produced as already described in chapter 3.2.1.7 
 
 Cell passaging: 
To passage, HUES9 cells were gently washed with DPBS and incubated with 
accutase (amount of volumes see table 25) for 4 minutes. The plate was agitated 
to help the colonies detach. When HUES9 colonies were dislodged, DMEM-F12 
was added, the cells collected and pelleted at 200 x g for 4 minutes to get rid of 
the accutase. The right amount of cell 32ignaling32 was taken and HUES-MCM 
and bFGF (100ng/µl) were added. Usually cells were passaged every 2 days 
1:10.  
 
 Maintenance of HUES cells in a pluripotent state:  
HUES9 cells could either grow on feeder cells (MEF) or on matrigel coated 
plates. 
Extracellular matrix components of Matrigel or feeder cells were necessary to 
maintain the pluripotent state. Additionally, the HUES9-MCM media had to be 
changed every day and the growth factor bFGF (100ng/µl) was added every day 
as well. 
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3.2.1.9 Culture of iPS cells 
 Production of iPSC-MCM: 
iPSC-MCM was produced as already described in chapter 3.2.1.7. 
 
 Cell passaging (mechanically): 
Single iPSC colonies were isolated under the EVOS microscope. 
The media was aspirated and 1ml new iPSC-MCM was added. The chosen 
colonies were dissected from the cell layer using a 26 gauge needle attached to 
a syringe. This layer was built up between MEFs, non-infected fibroblasts and 
iPSC colonies. Since the cell layer was sliced, the colonies could be easily 
removed by scratching them off with a 20ul pipet tip. The 1ml media and floating 
colonies were collected and transferred to a matrigel plate (production of matrigel 
plates, see chapter 3.2.1.8), where additional 2ml of iPSC-MCM and growth 
factor bFGF (100ng/µl) was added. 
 
 Pluripotent maintenance:  
iPSC colonies could either grow on feeder cells (MEF) or on Matrigel-coated 
plates. 
Extracellular matrix components of matrigel or feeder cells were necessary to 
maintain the pluripotent state. Additionally, the iPSC-MCM had to be changed 
every day and the growth factor bFGF (100ng/µl) was added every day as well. 
 
3.2.1.10 Generation of induced pluripotent stem cells 
Each independent iPS cell generation experiment required between 12 and 30 days and 
precise planning was critical. To start the iPS cell generation, the retroviruses containing 
the Yamanaka factors (KMOS or KOS) were produced as described in chapter 3.2.1.4 
and 3.2.1.5. On the same day of the retroviral transfection, one vial of frozen human 
fibroblasts was thawed and cultured as described in chapter 0 in a 10cm dish, to obtain 
100% confluency two days later.  
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Day 0 – Preparing fibroblasts 
One day before infection, fibroblasts were transferred and plated. Different densities 
were obtained by plating the cells as described in figure 3. After dissociation of a 10cm 
plate the cell suspension contains 10ml of media. Different amounts of cells were plated 
as shown in figure 3. Various cell densities were used to ensure that the proper cell 
density (50% confluency) for the retroviral infection would be achieved 24 hours later. 
 
 
Figure 3: Preparation of WT83 fibroblasts on day 0. Various used volumes (µl) of fibroblast cell 
suspension are indicated on the 6-wells. Additionally 3ml media was added. 
 
Day 1 – Fibroblast infection: 
A well of 50% confluency (see table 28) was chosen, the existing media reduced and 
200µl of the pooled Yamanaka cocktail (preparation see chapter 3.2.1.4) were added 
per 6-well. The cells were incubated for 5-6 hours at 37°C and media changed 
afterwards. 
Day 2 – Preparing feeder cells: 
The infected cells were left untouched in their well. If there was a lentiviral infection 
involved in the experiment, the Yamanaka transduced cells were transduced again that 
day (see chapter 3.2.1.3). 
Feeder cell plates were prepared as already described in chapter 3.2.1.7.  
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Day 3 – Cell transfer 
The protocol of chapter 3.2.1.2 was used to dissociate the infected fibroblasts and 
additionally, a cell scraper was used to detach all cells. They were transferred onto 
feeder cells in a proper density.  
Table 28: Seeding densities, dilutions and cell numbers 
Cell density Cell number Seeding dilution on 
day 3 
Cell number/6-well after cell 
transfer, according to 
seeding dilution 
Seeded cell 
number/cm
2
 
100% confluency 1.1 x 10^6    
50% confluency 
(recommended for 
transduction) 
5.5 x 10^5 1:6 9.2 x 10^4 10,222 
  1:12 4.5 x 10^4 5000 
  1:15 (recommended) 3.6 x 10^4 4000 
  1:30 (recommended) 1.8 x 10^4 2000 
  1:60 9.1 x 10^3 1011 
  1:120 4.6 x 10^3 511 
 
Day 4 – Changing into iPSC media 
The iPSC media was prepared by filtering all ingredients as listed in table 5 through 
0.2microns. 35ignali addition, a fresh and sterile stock of 10mM valproic acid (VPA) was 
prepared. The media was changed as described in 0 and additionally, cells were treated 
5 days (from day 4 until day 8) with VPA using a 1:1000 dilution (final VPA 
concentration = 10μM). VPA is a histone deacetylase inhibitor (HDAC inhibitor), which 
enhances the reprogramming process (Huangfu et al. 2008) 
The iPSC media replacement at 72 hours post-transduction was essential. If there was 
small molecule treatment involved in the experiment, treatment was started on day 4. 
Different small molecule treatments are described in chapter 3.2.1.11 
Day 5 – Day 10 – Cell feeding and treating every day: 
The next days, the media was replaced 0 and treated as described in chapter 3.2.1.11. 
Day 8 was the last day of VPA treatment. 
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Day 11 – Colony formation: 
From day 11 onward cells were treated as before except iPSC-MCM was used for 
feeding. iPSC-MCM production was described in chapter 0. 
 
3.2.1.11 Perturbing Wnt signaling pathway: 
 Through adding small molecules: 
In some experiments iPSC were treated with small molecules. Cells were treated 
every day at the same concentration until the cells were analyzed. The different 
small compounds were Wnt3a (stock = 2.5µM), Wnt5a (stock = 2.5µM) (both 
diluted 1:400), IWP (stock = 5mM, IWR (stock = 10mM) and the GSK3-inhibitor 
(Factor XV, stock = 10mM) used at various concentrations. 
 
 Through lentiviral overexpression or knock down: 
In other experiments lentivirus-mediated knock-down or overexpression of 
important Wnt pathway components were done. The lentiviral knock downs of 
Frizzled 7, ROR2 were performed and overexpressions of lenti-GFP, β-catenin 
and Axin. (for lentiviral constructs see table 11) 
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3.2.2 Microbiological and biological methods 
The preparation of buffers, chemicals, reagents and equipment is shown in chapter 3.1. 
3.2.2.1 Transformation: (chemical transformation and electroporation) 
Production of electro-competent bacteria (DH5α): 
E.Coli DH5α (35µl) in 10ml LB Media were inoculated overnight on 37°C. The next day 
inoculations with 1/100th Volume of the overnight culture were performed into twice 
500ml of LB Media. The 2 cultures were incubated on a shaker at 37°C until the OD600 
between 0.5 and 1.0 was reached. The cultures were centrifuged at 4000 x g for 15 
minutes at 4°C. Afterwards, their supernatant was poured off and the bacterial pellets 
resuspended in 500ml ice-cold distilled sterile water. This procedure was repeated twice 
but the centrifuge time was reduced to 10 minutes and at the 3rd wash the volume was 
reduced to 250ml per pellet.  
After the 3rd wash the pellets were resuspended in 20ml ice cold sterile 10% glycerol 
and pooled. Again the bacteria were centrifuged at 4000 x g for 10 minutes at 37°C, the 
supernatant aspirated and the pellet resuspended in 2-3ml ice cold sterile 10% glycerol. 
To store small aliquots for experimental use, the bacteria were aliquoted 50µl per tube 
and frozen at -80°C. 
 
Electroporation of plasmid DNA into electro-competent E.Coli DH5αe 
The Gene Pulser Cuvette (Biorad, 0.2cm) was chilled on ice before starting the 
transformation and the electro-competent bacteria were thawed on ice. After 
approximately 10 minutes, 50µl of bacteria and 1µl of Plasmid DNA were pooled, 
transferred into the cuvette and incubated on ice for 30 minutes. The Gene Pulser was 
set on “bacteria”. The cuvette was placed immediately in the holder and pulse button 
was pressed. The pulsed bacteria were removed from the holder, 1ml LB media was 
added and the suspension transferred into an sterileculture tube. The culture tube was 
incubated on the shaker 30 minutes at 37°C to allow the bacteria to recover and 
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express the antibiotic resistance marker encoded by the plasmid. While incubating, 
ampicillin plates were warmed up at room-temperature. For plating the right amount of 
bacteria, the transformed bacteria were spun. The pelleted bacteria were resuspended 
with 100µl LB Media. 20µl of the cell suspension was transferred and plated onto plates 
containing the appropriate antibiotics. The plates were sitting at room temperature until 
the liquid has been absorbed. The plate was inverted and incubated at 37°C over night. 
On the next day, transformed single colonies appeared on the plate. These colonies 
had the right DNA insert and were picked for bacterial cultures used for DNA 
proliferation and DNA purification (see chapter 3.2.3.1). 
Production of chemical-competent bacteria E.Coli DH5α: 
The production of the chemical-competent bacteria was performed by Willert lab, 
UCSD. 
Chemical transformation of plasmid DNA into chemical-competent E.Coli DH5α: 
A chemical transformation is generally less efficient than the electroporation.  
One vial of chemical competent bacteria was thawed on ice. After thawing for 10 
minutes, 1µl Plasmid DNA was added to about 30µl of bacteria. The mixture was 
incubated on ice for 30 minutes, followed by a heatshock at 42°C for 30 seconds and 
placed on ice again for 1-2 minutes. After the transformation procedure 500µl LB  Media 
was added and incubated on the shaker at 37°C for 45-60 minutes to allow the bacteria 
to recover and express the antibiotic resistance marker encoded by the plasmid. The 
following steps were performed as described in chapter 3.2.2.1(Electroporation). 
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3.2.3 Molecular biological methods: 
The preparation of the buffers, chemicals, reagents, equipment and kits is showed in 
chapter 3.1. 
3.2.3.1 DNA plasmid purification (Maxiprep): 
The NucleoBond Xtra Kit was used to purify DNA Plasmid.  
 Preparation of a starter culture: 
A 3-5ml starter culture of LB or Terrific Broth with a single colony picked from a 
freshly streaked agar plate was inoculated and incubated at 37°C and 300rpm for 
5 hours. 
 Preparation of a large overnight culture: 
Inoculations of overnight cultures were performed by diluting the starter culture 
1/1000 into the 300ml LB or Terrific Broth also containing the appropriate, 
selective antibiotic. The cultures were grown overnight at 37°C and 300rpm for 
12-16 hours. 
 Harvesting of bacterial cells: 
The cell culture OD600 was measured and the recommended volume was 
determined, according to the formula: V [ml] = 1200/OD600 
The chosen volume of cell culture was centrifuged at 6,000 x g for 10 minutes at 
4°C and afterwards, the supernatant discarded completely. 
 Resuspension, cell lysis, equilibration, neutralization, loading and washing: 
The pellet was resuspended in 12ml of resuspension buffer RES, already 
including Rnase A. After complete dissociation, 12ml of buffer LYS buffer were 
added to the suspension and the tube was gently mixed by inverting the tube 5 
times and incubated for 5 minutes. To equilibrate the NucleoBond Xtra Column 
25 ml of buffer EQU were applied to the rim of the column filter. 
After cell lysis the suspension was neutralized by 12 ml of buffer NEU and mixed 
by inverting the tube 10-15 times. The lysate was loaded immediately afterwards 
onto the freshly equilibrated NucleoBond Xtra Column Filter and was emptied by 
gravity flow. The filter and column was washed once by addition of 15ml buffer 
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EQU. After the liquid was filtered through, the filter was removed from the 
column. Another washing step was performed by adding buffer WASH onto the 
column. The purified DNA elution was done by adding 15ml of buffer ELU onto 
the column and collecting the liquid in a 50ml concial tube. 
 Precipitation: 
For proper precipitation 10.5ml room-temperature isopropanol was added, 
vortexed and incubated for 2 minutes. Afterwards, the tube was centrifuged at 
15,000 x g for 30 minutes at 4°C. The supernatant was removed and 70% room-
temperature ethanol was added and the pellet resuspended. Another 
centrifugation was started at 15,000 x g for 5 minutes at 4°C. Ethanol was 
removed carefully from the tube with a pipette tip and the pellet was dried at 
room temperature for 10-20 minutes. Finally the pellet was resuspended in 200ul 
TE Buffer (pH 8.0) and the DNA concentration was determined on the 
nanospectrometer. 
 Measurement: see 3.2.4.1 
 
3.2.3.2 RNA purification kit 
The Nucleospin RNAII kit was used to isolate RNA. The cells were washed with 1x 
PBS, scraped off the plate, collected in 1ml of 1x PBS and spun at 14,000 x g for 1 
minute. The pellet was lysed by 350µl buffer RA1 and 3.5µl 2-mercaptoethanol. The 
lysate was filtered by adding the viscous suspension onto the NucleoSpin filter and 
centrifuged at 11,000 x g for 1 minute. The filter was discarded, 350µl of 70% ethanol 
were added and mixed to adjust the RNA binding conditions. To bind the RNA the 
suspension was loaded onto NucleoSpin RNA II column and spun for 30 seconds at 
11,000 x g. 350µl of the membrane desalting buffer were added to the membrane and 
again centrifuged at 11,000 x g for 1 minute to dry the membrane. 
The preparation of Dnase reaction mixture was prepared as follows:  
 10µl reconstituted rDNase 
 90µl reaction buffer for rDNase 
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95µl of the mixture was applied directly onto the center of the silica membrane of the 
column and incubated for 15 minutes at room-temperature. Three membrane washes 
were performed by adding 200µl of RA2, 600µl of RA3 and spinning for 30 seconds at 
11,000 x g. This procedure was repeated one more time by adding 250µl RA3 and 
spinning for 2 minutes at the same speed. Finally, the RNA was eluted in 60µl Rnase-
free H2O and centrifuged for 1 minute at the usual speed. For measurement of RNA 
concentration see the chapter analytical methods. 
3.2.3.3 PCR – cDNA synthesis 
To successful synthesize cDNA, 1µg of RNA, 4µl of cDNA Supermix were mixed with 
ddH2O a final volume of 20µl. The cDNA was reverse transcribed on the PCR machine 
for 1 hour. The synthesized cDNA was stored at 4°C. 
3.2.3.4 Real-time quantitative PCR analysis 
qPCR of iPSC line containing all four factors and three factors was performed on the 
7900 HT Fast Real-Time PCR System (Applied Biosciences) using TaqMan® 
Mastermix (Gene Expression Assays – Applied Biosciences) and their lineage-specific  
gene primers. In this experiment the primers 18S (control), Nanog, Pou5f1 were used 
(Applied Biosciences). Mastermix, probes and dH2O were mixed as described in table 
29 and added onto the qPCR plate. At the end 200ng of DNA template were added in 
each well. 
The used cycle parameters for this specific qPCR are described in table 30. 
Table 29: Preparation of mastermix, probe and dH2O per sample 
ingredient amount (x1) amount (x7) 
TaqMan® Mastermix 10µl 70µl 
TaqMan® Probe 1µl 7µl 
dH2O 9µl 56µl 
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Table 30: Program of the cycle parameters for the real-time qPCR. 
step °C duration 
Initial Denaturation 50°C 2 min 
Enzyme Activation 95°C 10 min 
Denaturation 95°C 15 sec (40 cycles) 
Extension and primer 
annealing 
60°C 1 min (40 cycles) 
 
3.2.3.5 DNA gel electrophoresis 
The success of the DNA purification 3.2.2.1 was confirmed by electrophoresis on a 1% 
agarose gel and the DNA concentration was measured on the nanospectrometer. For 
the agarose gel 1% agarose was dissolved in 1x TAE buffer, melted in a microwave, 
10% sybr  safe (10,000x concentration in DMSO) added and poured into the gel 
chamber. A comb was used to create wells in the gel. After 15-20 minutes the gel was 
solidified and transferred in the running-equipment, which was then filled with 1x TAE 
buffer to cover the gel. The samples (for additional digestion see chapter 3.2.3.6) about 
0.3µg DNA were mixed with loading dye (1/5 of the total amount) and ddH2O (70% of 
the total amount) and were loaded on the gel. 6μl of the 1kb DNA ladder was loaded on 
the gel as well. The gel then was run for about 25 minutes at 100V. The gel was 
photographed using the gel documentation system. The isolated DNA was then used for 
a retroviral transfection, see chapter 3.2.1.4. 
 
3.2.3.6 Restriction digestion: 
Further improvement of successful DNA purification was given through a restriction 
digestion. Each plasmid DNA had restriction sites where specific restriction enzymes cut 
the strands. Every enzyme had their specific restriction enzyme buffer and BSA was 
added depending on the prescriptions. The samples were mixed with ddH2O (70% of 
the total amount) and enzyme mastermix. (10% of the total amount) 
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Enzyme mastermix: 
 10% Restriction enzyme  
 90% Restriction enzyme Buffer 
To achieve a digestion, the samples were incubated on 37°C for 1 hour. After the 
digestion, 20% loading dye was added to each sample and the DNA gelelectrophoresis 
performed (see chapter 3.2.3.5). 
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3.2.4 Analytical methods 
The preparation of the buffers, chemicals, reagents, equipment and kits is showed in 
chapter 3.1. 
3.2.4.1 Nanospectroscopy 
The concentration of purified plasmid DNA or RNA was detected on the 
nanospectrometer.  
Measurement of DNA concentration: For equilibration and blank TE Buffer (pH 8.0) was 
required. Ratios of 260:280 were recommended between 1.7 and 1.9 and 
concentrations usually about 2-4 µg/µl. 
Measurement of RNA concentration: The same technique was used as for DNA 
measurement, just the blank was Rnase-free H2O. 
 
 
Between day 7 and day 23 different analytical methods were performed to find the best 
method with low background and clear read out, regarding iPSC generation efficiency: 
3.2.4.2 Alkaline phosphatase (AP) staining in situ and colony counting using Adobe 
Photoshop or Cellomics Arrayscan Vti. 
The culture medium of the iPSC plates was aspirated and washed twice with 1x PBST. 
To fix them, 1ml of fixing solution (Paraformaldehyde solution) was added and 
incubated for 1-2 minutes. The cells should not be over-fixed, which would result in the 
loss of AP activity. Afterwards the fixing solution was aspirated, washed once with 1x 
PBST and the staining solution (solution A: sodium nitrate solution; solution B: fast red 
violet solution - substrate: napthol AS-BI phosphat) was prepared at a ratio of 1:1 right 
before the staining process. Accordingly, 500µl freshly prepared staining solution were 
added and incubated 5-15 minutes in the dark. The color change was closely monitored 
every 2-3 minutes to avoid non-specific staining and the reaction was stopped when the 
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color turned bright by aspirating the staining solution and washing 3 times with 1x PBS. 
AP expression produces a purple stain, while the absence of AP expression showed no 
stain. For storage, the well was covered by 500µl 1x PBS to prevent drying and stored 
at 4°C.  
Every well was photographed to quantify colonies, the counting function of  Adobe 
Photoshop was used, and purple stained colonies were counted.  
3.2.4.3 Flow cytometry and staining for Tra1-81 or SSEA-4 
Cell dissociation: 
The cells (= induced pluripotent stem cells growing on MEF feeder cells and some non-
reprogrammed fibroblasts) were washed with DPBS Buffer and for dissociation filter-
sterilized 1mg/ml collagenase IV (1ml/6well, 5ml/10cm) was added. After 1 hour the 
cells were coming off their feeder cells. For better dissociation they were pipetted up 
and down and transferred to a 15ml conical tube. The wells were washed with 3ml of 
DMEM-F12, also added into the tube and centrifuged at 200 x g for 4 minutes. 
Afterwards, the supernatant was aspirated, and 5ml of FACS Buffer have been added to 
the cells. For all further steps has been worked on ice. To achieve single cell 
suspension the cells have been transferred through a cell strainer and counted. 
Cell counting: 
Preparation for cell counting: 
 10µl of single cell suspension 
 10µl of Tryphan Blue 
10µl of the preparation was counted using the haemocytometer.  
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Figure 4: Haemocytometer (http://static.flex.com/pictures/3/1/0/t/Haemocytometer_Grid.png) 
The cells located in chamber 1 and 4 (marked in figure 4) were counted. If tryphan blue 
entered in the cells, these cells were considered dead and were not counted. The 
counted number of cells was divided by two, multiplied by 10,000, the dilution factor and 
the total volume, see formula below. 
Total number of cells = number of cells (counted) x 10,000 x dilution factor x total 
volume of sample 
The chosen cells were transferred into a FACS tube and incubated with the appropriate 
antibody. 
Antibody staining: 
Preparation mix for antibody staining per sample: 
 100µl FACS buffer 
 2.5µl antibody for 500.000 cells 
The desired number of cells were centrifuged at 200 x g for 4 minutes, the supernatant 
aspirated and the pellet mixed with 102.5µl of preparation mix and incubated 10 to 30 
minutes at 4°C in the dark. 
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Cell washing: 
After the staining procedure the cells were washed properly 3 times. 1ml of FACS buffer 
was added, pellet resuspended and centrifuged again at 200 x g for 4 minutes. After the 
last wash, 350µl of FACS buffer was 47ignali into each FACS tube. 
Flow cytometry on BD FACS CantoII (BD Biosciences): 
To set up the machine proper controls were always required. HUES9 cells with equal 
preparation and antibody staining as all the samples, functioned as positive control and 
an Isotype Control was used as negative control. Fluorochromes used in this analysis 
are listed in table 31. 
Table 31: Flourochromes and wave lengths according to 
(http://www.bdbiosciences.com/documents/Multicolor_Fluorochrome_Specs.pdf) 
 Fluorescence 
Emission 
Color 
Ex-Max(nm) Excitation Laser 
Line(nm) 
Em-Max(nm) 
Alexa Flour 647 
(APC) 
red 650 595,633,635,640,647 668 
PerCP-Cy5.5 far red 482 488,532 695 
FITC green 494 488 519 
 
After running the samples the flow cytometer was cleaned with bleach and ddH2O. 
 
3.2.4.4 Flow cytometry and staining for alkaline phosphatase (AP) expression 
Cell dissociation and cell counting were done as in chapter 3.2.4.3.  
Alkaline phosphatase (AP) staining: 
The cells were centrifuged at 200 x g for 3 minutes and fixed 1-2 minutes with 400µl of 
the AP kits (Stemgent, see table 13) fixing solution. By adding 20µl of 2.6M glycine 
solution the fixing process was quenched and washed twice by 1x PBST; 1ml has been 
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added, pellet resuspended and centrifuged again at 200 x g for 4 minutes. The cells 
were stained with 200µl of AP staining solution, prepared at a ratio 1:1 containing 
solution A and B (see chapter 3.2.4.2), for 1-2 minutes and then immediately washed to 
avoid non-specific staining. 
Cell washing and flow cytometry: 
The washing procedure and flow cytometry was performed as already described in 
chapter 3.2.4.3. 
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4 Results 
4.1 Method for induction of pluripotency 
4.1.1 Method 
The goal of the experiment was to generate iPS cells and evaluate their efficiency under 
different conditions related to the Wnt Pathway. The experimental procedure is precisely 
presented in chapter 3.  
Summarizing chapter 2, the method of iPS cell generation was invented 2006 by 
Yamanaka (Yamanaka et al. 2006). 4 factors (Oct4, Klf4, Sox2 and c-Myc) were 
retrovirally transduced into adult human foreskin fibroblasts. Changing the cell culture 
conditions (changing the microenvironment and equal treatment as human embryonic 
stem cells) on day 3 post-transduction causes induced pluripotent stem cell colonies 
emergence approximately one week later. 
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Figure 5: Schematic timeline of general iPSC colony formation with 4 factors (Oct4, Klf4, Sox2, c-Myc)  
A, General description of the reprogramming process. 1, fibroblast cell with yellow nucleus = 
untransduced; 2, fibroblast with red nucleus = after transduction; 3, induced pluripotent stem cell; 4, plate 
with individual induced pluripotent stem cell colonies; B, Exact time schedule; in light green: either starting 
small molecule treatment or lentiviral overexpression/knockdown; in grey: indication of fibroblast seeding, 
cell infection, microenvironment change and human embryonal stem cell conditions in cell culture; 
emerging of ESC-like colonies; two analysis methods: alkaline phosphatase staining and analysis on flow 
cytometer 
 
Figure 5A depicts a wildtype (WT83) adult human fibroblast cell (origin see chapter 
3.1.2), a cell transduced with the reprogramming factors (red nucleus), and the 
reprogrammed cell and individual iPSC colonies in a dish. Figure 5B shows a more 
detailed timecourse. Day 0 the WT83 – adult human fibroblasts were seeded in the right 
(50% confluent, see figure 3) density. The next day four Yamanaka factors (KMOS) 
were transduced retrovirally into those fibroblasts. The microenvironment was changed 
on day 4. The cells were transferred onto MEF feeder cells (see chapter 3.1.2) and on 
day 5, the media was changed into human embryonic stem cell-like condition (Figure 
5B). Additionally, for perturbing the Wnt signaling pathway (see chapter 3.2.1.11) the 
lentiviral infection was performed on day 2 and small molecule treatment with soluble 
Wnt components was started on day 4. 
The first ESC-like colonies emerge between day 8 and day 12, depending on the titer of 
the virus and on the transduction efficiency. In the case of an alkaline phosphatase 
staining, colonies were fixed and stained on day 14, otherwise the cultures were 
analyzed on the flow cytometer (see chapters 3.2.4.3 and 3.2.4.4) between day 8 and 
day 20. Furthermore, the whole reprogramming process was alternatively performed 
with only three factors (without c-myc, see chapter 3.2.1.5) 
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4.1.2 Gelelectrophoresis 
 
Figure 6: Restriction digestion of plasmids carrying the four reprogramming factors (Oct4, Sox2, Klf4, c-
Myc). L, 1kb DNA ladder O‟Gene Ruler, 250-10.000 bp; Arrowheads are indicating the small DNA 
fragments 
 
Figure 6 illustrates a 1% agarose gel verifying the plasmid DNA of the four 
reprogramming factors. The DNA isolation was done using the NucleoBond Kit –
Macherey-Nagel and 0.3µg DNA were digested with Not I (Sox2, Klf4, c-Myc) and 
EcoRI (Oct4) and then loaded on the gel. The concentration of the isolated DNA was 
determined using the nanospectrometer. 
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4.1.3 Assaying iPSC generation 
 
Figure 7: Schematic of iPSC colony generation in 6-well 
 
The two wells on the left in Figure 7 show non-transduced WT83 fibroblasts. Cells in the 
middle wells were transduced with 3 factors and the wells on the right were transuced 
with 4 factors (Oct4, Klf4, Sox2, c-Myc). 
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Figure 8: Assaying iPSC generation; A-F, biological replicates of negative control, 3 factor and 4 factor 
iPS cell generation in a 6-well plate (labeled below); G-I, bright field images 
 
Figures 8A-F show the number of alkaline phosphatase-positive iPSC colonies on day 
14 growing on MEF feeder cells. Cells were transduced with 0 (A and D), three (w/o c-
myc, B and E) and four factors (C and F), according to the schematic in Figure 7. A and 
D, B and E, and C and F are biological replicates. On day 3 post-infection cells were 
passaged at 1:12 from the plate of infected fibrobasts. Thereafter, cells were not 
passaged. According to table 28 (see chapter 3.2), around 5000 cells were seeded per 
cm2. Non-transduced WT83 fibroblasts (Fig. 8 A and D) were treated in the same media 
conditions as transduced cells and served as negative controls. 
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Figure 8G, H and I are bright field images of WT83-adult human fibroblasts (passage 
14), three factor and four factor transduced WT83 fibroblasts. In Figure 8 H and I colony 
formation is visible on day 14. A black round-shaped mark used to observe an emerging 
colony on a daily basis is visible on the right side of the picture in Figure 8I. 
 
As a separate experiment, I tried to establish two iPS cell lines by myself (bright field 
images, see figure 15 and 16), which were analyzed in this assay. A qPCR assay was 
done, to show the differences of Nanog and Oct4 expression in two established cell 
lines: an iPS cell line, which was transduced with 3 factors and another one transduced 
with 4 factors.  
 
Figure 9: Quantitative real-time PCR analysis of putative iPSC clones (two clones). The analysis was 
done in triplicates (errorbars). The bars show the difference of specific gene expression in 4 factor and 3 
factor transduced iPS cells (data does not include controls). 
 
Figure 9 shows Nanog (A) and Oct4 (B) expression in iPS cells transduced with three 
factors compared to iPS cells transduced with four factors. Primers for Oct4 were 
specific for the endogenous gene and do not amplify the transgene transcript. qPCR for 
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Oct4 and Nanog were performed on two clones which were manually passaged 7 times 
(chapter 3.2.1.8). The first passage was done on day 15 post-infection onto matrigel 
and afterwards cultured until day 53 (7 passages) and fed every day (Media, bFGF). 
 
4.1.4 Efficiency assays  
The goal of this project was to study the influence of Wnt signaling on iPSC generation. 
We utilized several approaches to perturb Wnt signaling during iPSC generation and 
tested several assays to quantify reprogramming efficiencies.  
 Flow cytometry: 
o Alkaline phosphatase staining (for experimental procedure, see chapter 
3.2.4.4) 
o Antibody 55ignaling (data not shown) 
o Tra1-81 and SSEA-4 staining (for experimental procedure, see chapter 
3.2.4.3) 
 
 Alkaline phosphatase staining with colony counting (for experimental procedure, 
see chapter 3.2.4.2) 
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Figure 10: Flow cytometry analysis of human pluripotent stem cells. Red: adult human fibroblasts 
(negative control); human embryonic stem cells = HUES9 (positive control); 
 
Figure 10A and B show fixed alkaline phosphatase-stained cells detected by flow 
cytometery with the fluorochrome PerCP-Cy5, according to table 31 (see chapters 
3.2.4.3 and 3.2.4.4).  The PerCP-Cy5 settings of the BD FACS CantoII were assumedly 
used to detect the alkaline phosphatase stained cells. 
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Flow cytometry of two control cell lines (adult human fibroblasts and HUES9 cells) 
yields two distinct peaks, demonstrating that hESCs have higher AP activity than 
fibroblasts. As shown in Figure 10B, the difference is detectable in several cell lines 
using flow cytometry. However, we decided that these differences were not robust 
enough to allow us to apply this AP staining assay as a quantitative assay to detect 
iPSC generation efficiencies. In contrast, cells stained with a pluripotent stem cell 
surface marker Tra1-81 (Figure 10C) conjugated with fluorochrome APC (see table 31) 
showed a strong separation in signal strength between adult human fibroblast and 
human embryonic stem cell. We concluded that this difference in Tra1-81 staining on 
hESCs and fibroblasts was sufficiently large that this stain would serve as a robust 
assay to quantify iPSC generation by flow cytometry (see results figure 30). 
 
 
Figure 11: Method of counting colonies by Adobe Photoshop CS5. A, B are one equal 6-well with iPS 
cells (KMOS) stained for alkaline phosphatase on day 14; A, shows the counts additional to the stained 
colonies; B, just the AP staining for comparison 
 
Figure 11A and B illustrate the same well of iPSC colonies, where A shows colony 
counts. In this experiment iPS cells were transduced with four factors (KMOS) and 
grown on MEF feeder cells. Colonies were fixed and stained for AP on day 14. Adobe 
Photoshop CS5 was used for analyzing the colony numbers. All visible and stained 
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colonies were counted using the counting tool. After every count the number appeared 
on the colony (see figure 11), to simplify the time-consuming evaluation process. Colony 
counts were performed in a blinded fashion by several lab members. 
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4.1.4.1 Pictures of general iPSC generation 
This chapter contains images of  all used cell lines. Their origin was described in 
chapter 3.1.2 and their culturing methods were described in chapter 3.2.1. 
 
Figure 12: Phase contrast microscopy images of cell lines used in these studies.  
(bars with proper size in the right corner of each figure) 
Irradiated mouse embryonic fibroblasts (MEF, Figure 12 A, also see chapter 3.1.2) 
serve as feeder cells for hESCs and secrete several important growth factors and 
provide a cellular matrix for hESCs and iPS cells. Human embryonic kidney cells (HEK 
293T, Figure 12 B and C) were used to generate the viral vectors for the infection of 
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human fibroblasts. Figure 12D, E and F demonstrate one iPSC colony on day 10 at 
three different magnifications and G and H another iPSC colony on day 14. These iPSC 
colonies were derived from adult human fibroblasts, called WT83 and were grown on 
irradiated MEF feeder cells. The iPSC colony in Figure 12G exhibits several 
characteristics of ES cells, including defined borders, round shape, large nucleoli and 
scant cytoplasm for each cell. HUES9 cells (Figure12I, J and K), a human embryonic 
stem cell line, were included in these studies as positive controls. The images shown in 
Figure 12 I-K illustrate slightly differentiated hESCs as evidenced by the rough borders. 
Figure 12D and E show a black round-shaped labeling on the right side of the picture, 
which was used to mark the colony and observe the same colony every day. 
 
 
Figure 13: Phase contrast images of human fibroblasts in an early stage of iPSC generation (bars with 
proper size in the right corner of each figure). 
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Figure 13A-D illustrate infected and uninfected human fibroblasts at day 2 and 3 post-
infection prior to passaging them onto MEF feeder cells. Day 2 or 3 post-transduction, 
cells were still in normal fibroblast culture conditions. Figure 13A and C show non-
infected fibroblasts at day 2 and 3, and B and D infected ones. Cells in Figure 13D show 
a drastic difference compared to cells in Figure 13B which can be attributed to the 
transuction of the reprogramming factors KMOS. This timeline is being continued in 
Figure 14. 
 
 
Figure 14: Timeline of iPSC generation (bars with proper size in the right corner of each figure) 
Cells on days 4-23 were cultured on irradiated MEF feeder cells and fed every day. In 
Figure 14A-F cells were photographed on different days as they acquire iPSC 
properties. Images in Figure 14G-I are at a higher magnification. In Figure 14A-D the 
same field of cells (as marked with a colony marker) was photographed to monitor the 
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progression of iPSC generation. On days 14 to 23 (Figure 14E and F) defined borders 
characteristic of human pluripotent stem cells become visible. 
4.1.4.2 Isolation of iPSC clones 
Colonies with characteristics of iPSCs (see Figure 14E) were manually isolated and 
passaged over 34 days (Figure 15). The isolated iPSC line was used to confirm that 
cells were reprogrammed and acquired a pluripotent state. For the experimental 
procedure see chapter 3.2.1.8. As already described in chapter 4.1.3 (figure 9) this 
experiment was done as separate assay to examine the possibility of establishing an 
iPS cell line. The clones were analyzed by qPCR on day 53. 
 
Figure 15: Isolation of iPSC clones (w/o C-MYC). A, after the 1
st
 passage cells still do not appear ESC-
like; only KOS transduced, colonies need longer until appearing ESC-like (B); B,C, cells around the iPSC 
colonies are either not infected adult human fibroblasts, differentiated iPS cells or unintended transferred 
MEF feeder cells; D, three well defined iPSC colonies with distinct borders  
(bars with proper size in the right corner of each figure) 
Figure 15A-D show manually isolated iPSC clones (three factors) growing on matrigel 
on day 15-34. Cell passaging (see chapter 3.2.1.9) was performed on day 14 post-
transduction using the EVOS microscope. Two clones were transferred and Figure 15A 
shows one of those clones. They underwent 3 more passages (Figure 15B and C) until 
day 34 (Figure 15D), where they appeared more like iPSC colonies. Figures 15B and C 
show plenty of fibroblasts, which is a consequence of the manual isolation technique. 
These cells were growing until day 53 (three additional passages) and then analyzed by 
qPCR. 
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Figure 16: Isolation of iPSC clones (KMOS). A, after 1
st
 passage cells still do not appear ESC-like; B,E 
well defined iPSC colonies with distinct borders; Generally, the cells around the iPSC colonies are either 
not infected adult human fibroblasts, differentiated iPS cells or unintended transferred MEF feeder cells; 
C,F,H in the center: iPS cells, on the rim: adult human fibroblasts; D,G iPSC colonies which have unusual 
morphology; they grow planar and also for 3D cell aggregates (dark colony in G)  
(bars with proper size in the right corner of each figure) 
Figure 16A-H show manually isolated iPSC clones (four factors) grown on matrigel (BD, 
see chapter 3.2.1.8) on day 15-34. The iPSC colonies were isolated from human 
fibroblasts transduced with the four Yamanaka factors KMOS on day 1. Two colonies 
were manually passaged on day 14 post-transduction, underwent four passages until 
day 34 (Figure 16D and G). Figure 16C, F and H show the same colony after three 
passages in different magnifications on day 33. The colonies have defined borders, but 
reveal unusual iPSC morphology, as they were growing in three dimensions (dark 
colony Figure 16G). White 3D cell aggregates or tumular colonies were detected by the 
unaided eye. This was an unusual discovery for the iPSC generation process. Probably 
a tumor formation occurred (data not shown). 
After the first passage on day 15 (Figure 16A), the colony was hardly visible and still did 
not appear fully reprogrammed. After several additional passages (Figure 16B, E, C, D 
and G) cells started to exhibit defined borders by day 34. However, there was no 
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observation of an iPSC colony confluent well. The cells were cultured three additional 
passages until day 53 and analyzed by qPCR. 
4.1.4.3 Virus control 
 
Figure 17: Fluorescence microscopy of GFP-expression after retroviral transfection (A) and virus 
transduction/infection (B); (bars with proper size in the right corner of each figure) 
HEK 293T cells transfected with a retrovirus (for retroviral transfection, see chapter 
3.2.1.4 and also background in chapter 2.1.3) carrying a constitutively expressed GFP 
were expressing GFP as evidenced by the fluorescence signal. Infection of hESC 
(HUES9) with the virus obtained from the transfected HEK 293T cells yielded GFP 
expressing cells as expected. Untransduced cells showed no GFP-expression (data not 
shown). The virus titer was not determined. 
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4.2 Effect of Wnt 3a and Wnt5a on iPSC generation 
General procedures were performed as described in chapter 3.2.1.4 and Figure 5.  In 
the next chapters, flowcharts are presented to illustrate how and when the Wnt signaling 
pathway was perturbed.  
The attention was always focused on comparable conditions and consistent iPSC 
generation while treating with small molecules or overexpressing and knocking down 
genes. The efficiency of iPSC generation was only scored and compared within 
individual experiments because slight difference in conditions, such as viral titer and 
seeding density, can drastically alter the number of iPSC colonies per dish. 
The following data contains three different batches of iPS cell generation with their 
treatments, which were diversified for optimal read-out. In the first set, presented in 
chapter 4.5, the infected adult human fibroblasts were transferred into wells without 
dilutions (1:1) and then analyzed on the flow cytometer. In the second one (presented in 
chapter 4.4), we tried to find out the best cell density to grow and reprogram to optimize 
our comparison. Therefore we compared four different dilutions. We plated infected 
adult human fibroblasts at dilutions of 1:6, 1:12, 1:60, 1:120 into 6-wells and stained 
with alkaline phosphatase. The results of the last and most significant iPSC generation 
are recorded in this chapter (4.2) and also chapter 4.3. We decided to use two dilution 
numbers, which, in the last batch (4.4), resulted to be the most meaningful cell colony 
numbers to compare and used 1:15 and 1:30 dilutions. 
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4.2.1 Time course for Wnt3a and Wnt5a small molecule treatment 
 
Figure 18: Time course for Wnt3a and Wnt5a small molecule treatment. 
The timeframe of treating with Wnt proteins (Wnt3a or 5a) is illustrated in Figure 18 and 
the day of fixing and staining with alkaline phosphatase is indicated.   
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4.2.2 Alkaline phosphatase stain of Wnt3a and Wnt5a treated cells 
 
 
Figure 19: iPSC colonies (KMOS transduced) with Wnt3a and Wnt5a treatment stained for alkaline 
phosphatase; A-F, AP stained colonies in 6-wells; G, graph of untreated, +Wnt3a, +Wnt5a iPSC colonies 
in 1:15 and 1:30 dilution; generally, all experiments were done in duplicates (errorbars) 
 
Cells transduced with the reprogramming factors were not treated (Figure 19A and B), 
treated with Wnt3a (C and D) or treated with Wnt5a (E and F) and then stained for AP 
activity in 6-well dishes. In Figure 19C and D standard iPSC generation was performed 
with Wnt3a treatment, and Figure 19E and F with Wnt5a treatment. The number of 
colonies was counted and illustrated in a chart format in Figure 19G. After KMOS 
transduction cells were either seeded at 1:15 (A,C and E) or at 1:30 (B, D, and F). The 
effects of Wnt3a and 5a treatment were most pronounced in the 1:15 dilution. The 1:30 
dilution refused significant varieties. 
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Figure 20: iPSC colonies without c-myc (KOS transduced) with Wnt3a and Wnt5a treatment stained for 
alkaline phosphatase; ; A-F, AP stained colonies in 6-wells; G, graph of untreated, +Wnt3a, +Wnt5a iPSC 
colonies in 1:15 and 1:30 dilution; generally, all experiments were done in duplicates (errorbars) 
 
Figure 20A and B were AP stained 6-wells of standard iPSC generation KOS 
transduced without specific treatment. In Figure 20C and D three factor standard iPSC 
generation was performed with Wnt3a treatment or in Figure 20E and F with Wnt5a 
treatment. The chart in Figure 20G illustrates the number of alkaline phosphatase 
positive-counted colonies compared within the three different conditions. The relations 
1:15 and 1:30 represent the dilution of seeded infected fibroblasts on day 3. 
Therefore, the efficiency of iPSC generation in cells transduced with KOS was 
significantly increased in the presence of Wnt3a, while Wnt5a had an insignificant 
effect. 
  
69 
 
4.3 Effect of small molecule Wnt pathway agonists and antagonists on 
iPSC generation 
To investigate the effect of ectopic Wnt signal activation, cells undergoing 
reprogramming were treated with small molecules (IWP, IWR and GSK3-inhibitor in 
various concentrations). 
4.3.1 Time course for small molecule treatment of Wnt pathway agonists and 
antagonists 
 
Figure 21: Time course for small molecule treatment of Wnt pathway agonists and antagonists 
The timeframe of small molecule treatment, which act as Wnt agonists and antagonists 
is illustrated in Figure 21 and the day of fixing and staining for alkaline phosphatase is 
indicated. For the whole iPSC generation process see Figure 5 and Figure 14. 
 
4.3.2 Alkaline phosphatase stain of GSK3-inhibitor, IWP and IWR treated cells 
4.3.2.1 Small molecule treatment with GSK3-inhibitor (Factor XV) 
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Figure 22:  iPSC colonies (KMOS transduced) with GSK3-inhibitor treatment stained for alkaline 
phosphatase; generally, all experiments were done in duplicates (errorbars); uM=µM 
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Cells, which were transduced with four factors in Figure 22A-F, were treated with 
different doses of GSK3-inhibitor (1µM, 0.1µM, 0.01µM). Figure 22A-C show AP stained 
6-well plates of the three dose treatments and Figure 22D-F bright field microscopy 
images according to the AP picture above. Figure 22G illustrates the numbers of 
counted colonies compared to different culture conditions. The relation 1:15 represents 
the dilution of seeded infected fibroblasts on day 3. GSK3-inhibitor treatment was toxic 
to the cells regardless of whether low or high concentration. 
 
Figure 23:  iPSC colonies without c-Myc (KOS transduced) treated with GSK3-inhibitor stained for alkaline 
phosphatase; generally, all experiments were done in duplicates (errorbars); uM=µM 
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Compared to Figure 22, cells in Figure 23 were transduced with KOS. Figure 23A-C and 
E-G were treated with three different doses of GSK3-inhibitor. Figure 23A-D show AP 
stained 6-well plates and Figure 23 E-H bright field microscopy images of the three 
dose treatments and one untreated control. The chart (Figure 23I) compares four 
different culture conditions. The relation 1:15 represents the dilution of seeded infected 
fibroblasts on day 3.  
Regarding the untreated iPSC colonies in Figure 22, a 12-fold higher bar was detected. 
Certainly, a three factor transduction, led to less colony production. Though, the 0.01µM 
treatment with GSK3-inhibitor enhanced the iPSC colony formation 6-fold in KOS 
transduced iPSC colonies. Through GSK3-inhibitor adding at the lowest dose, Wnt 
target genes were activated and colony formation was enhanced, especially lacking c-
myc. 
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4.3.2.2 Small molecule treatment with inhibitor of Wnt production (IWP) 
 
Figure 24: iPSC colonies (KMOS transduced) with three different doses of IWP concentration; generally, 
all experiments were done in duplicates (errorbars); uM=µM 
Cells were transduced with KMOS (Figure 24A-C) and treated with different doses of 
IWP (5µM, 0.5µM, 0.05µM). The images demonstrate AP stained 6-well plates of the 
three dose treatments. Figure 23D illustrates the number of counted colonies compared 
to different culture conditions in a chart. The relations 1:15 represent the dilution of 
seeded infected fibroblasts on day 3. Treating with IWP resulted into approximately 2-
fold colony reduction. iPSC colonies without c-myc transduction did not show any 
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positive stained colonies (data not shown). The inhibition through IWP and the lack of c-
myc led to a total inhibition of iPSC production. 
4.3.2.3 Small molecule treatment with inhibitor of Wnt response (IWR) 
 
Figure 25: iPSC colonies (KMOS transduced) with three different doses of IWR concentration; generally, 
all experiments were done in duplicates (errorbars); A,C show no iPSC colony formation at all, probably a 
mistake occurred; I, J bright field images according to A and B; K graph illustrates 1:15 and 1:30 dilution 
to get a more conclusive chart; uM=µM 
Cells undergoing reprogramming with KMOS were treated with different concentrations 
of IWR. The images (Figure 25A-F) demonstrate AP stained 6-well plates with different 
treatments labeled in the figure. For comparison, standard reprogramming mechanism 
without IWR addition was displayed in Figure 25G and H.  Figure 25 I and J show bright 
field microscopy according to the AP stained 6-wells (Figure 25A and B). The chart in 
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Figure 25K compares the three dose treatments and the number of AP-positive counted 
colonies. The relations 1:15 and 1:30 represent the dilution of seeded infected 
fibroblasts on day 3. 1:15 dilution result did not show a convincing effect. However, the 
1:30 dilution did direct into a contradictory result. The highest concentration of IWR 
doses led to approximately the same colony number as the untreated control. Whereas, 
the 1µM and 0.1µM concentrations lowered the colony formation process. iPSC 
colonies without c-myc transduction did not show any positive stained colonies (data not 
shown). The interaction of the inhibiting deed of IWR and the absence of c-myc reveal 
into total inhibition of iPSC production. 
 
4.4 Effect of overexpression of Wnt pathway components Axin and β-
catenin on iPSC generation 
The experiment of overexpressing Axin and β-catenin in cells undergoing the 
reprogramming mechanism was performed in a separate batch apart from the previous 
ones. Different amounts of infected adult human fibroblasts at dilutions of 1:6, 1:12, 
1:60, 1:120 were plated, stained with alkaline phosphatase and compared in 6-wells 
(1:60 and 1:120 data not shown). 
All general procedures were performed as above (chapter 3.2.1.4 and Figure 5).  
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4.4.1 Time course for overexpression of Wnt pathway components 
  
Figure 26: Time course for overexpression of Wnt pathway components 
Cells were transduced with KMOS or KOS, as already described in Figure 5. The 
timepoint of Wnt pathway component overexpression was indicated in the image above 
(Figure 26) as well as the day of evaluating the experiment by alkaline phosphatase 
staining. 
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4.4.2 Alkaline phosphatase stain 
 
Figure 27: iPSC colonies (KMOS transduced) with overexpression of Axin and β-Catenin; A-C,E-G iPSC 
colony formation under different conditions; D,H two control plates; I shows twice almost the same pattern 
in two separate diluted (1:6, 1:12) experiments; generally, all experiments were done in duplicates 
(errorbars);  
Standardly produced iPSC colonies (transduced with KMOS) were used as positive 
controls (Figure 27C and G) and Figure 27D and H shows two different negative 
controls. In Figure 27A,B and E,F the iPSC colony generation was affected by 
overexpression of two important Wnt pathway components, Axin and β-Catenin. The 
chart in Figure 27I illustrates AP-positive colonies of three variously treated iPSC 
generations and two controls. The relations 1:6 and 1:12 represent the dilution of 
seeded infected fibroblasts on day 3 and OE signifies overexpression. The blue and the 
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red bars in Figure 27I gave just a slight upregulation of the β-catenin treated cells, which 
is not very significant and has to be repeated in future. Another proof for lacking 
significance is the high errorbar on the red column in the 1:12 dilution experiment. 
Whereas, Axin showed a more consistent colony reduction. 
 
Figure 28: iPSC colonies without c-myc (KOS transduced) with overexpression of Axin and β-catenin; A-
C,E-G iPSC colony formation under different conditions;  D,H two control plates; I chart, showing 
experiments in two different dilutions; generally, all experiments were done in duplicates (errorbars) 
 
Standard iPSC colony formation with KOS transduced cells affected by overexpression 
of two Wnt pathway components shown in images 28A, B and E, F. Figure 28C and G 
were iPSC colonies performed standardly with three factors used as positive control and 
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Figure 28D and H were used as two different negative controls. The chart in Figure 28I 
illustrates AP-positive colonies of three variously treated iPSC generations without c-
myc and two controls. The relations 1:6 and 1:12 represent the dilution of seeded 
infected fibroblasts on day 3 and OE means overexpression. Regarding figure 28I and 
the red bars (β-catenin), lacks consistency. Whereas, the green bar (+ Axin) showed a 
consistent reduction compared to the blue bar. Moreover, the reduction concerning blue 
and green bars was also regressing according to their dilutions.  
4.5 Effect of shRNA-mediated knockdown of Wnt pathway components 
FDZ7, ROR2 on iPSC generation  
In this experiment, cells underwent standard reprogramming while lentiviral shRNA-
mediated knockdown of Wnt pathway components and also other Wnt dependent 
treatments. As it was the first set we tried, the cells were not diluted, and all the growing 
cell densities were 1:1. Flow cytometry was used for the evaluation process, which was 
not significant enough. All general procedures were performed as above (chapter 
3.2.1.4 and Figure 5 and 14).  
4.5.1 Time course for knockdown of Wnt pathway components 
 
Figure 29: Time course for knockdown of Wnt pathway components 
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Figure 29 represents the timepoints of lentiviral shRNA-mediated knockdown of 
important Wnt pathway components and the day of evaluating pluripotent cells by flow 
cytometry. Timepoints of other Wnt dependent treatments see Figure 26, 21 and 18. 
4.5.2 Flow cytometry analysis 
In the first set, the infected adult human fibroblasts were transferred into wells without 
dilutions (1:1) and then analyzed on the flow cytometer. 
 
Figure 30: Scattered-plots of flow cytometry expression analysis of the human cell surface marker Tra1-
81 on iPS cells transduced with KMOS with different treatments; FITC = control; E, FITC positive results, 
because of GFP expression; D,H 1:500 signifies the dilution; D,H,K,L e.d.t = every day treatment; F,J OE 
= overexpression; G,I KD = knock down;  
This assay was performed on day 14 post-transduction of KMOS by counting 10.000 
cells on the flow cytometer (BD FACS Canto II). The scattered-plots compare the APC 
versus the FITC intensity. They illustrate all cells and show how many of those 10.000 
cells were stained for Tra1-81, which is pointed out by the number remarked in the 
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lower right corner of each plot. The iPSC generation was perturbed with many different 
Wnt pathway-dependent treatments, included the shRNA-mediated knock down of 
Frizzled 7 (Figure 30G) and ROR2 (Figure 30I). Figure 30A shows one positive control 
(HUES9), B, one negative control (Isotype control) and C, standardly reprogrammed 
cells transduced with KMOS. Figures 30D-L are four factor transduced iPS cell 
formations with different treatments, labeled in the figure.  
 
 
Figure 31: Efficiency numbers indicated of counting 10.000 cells (see Figure 30) 
This chart exemplifies the efficiency of Tra1-81 positive cells after standard 
reprogramming (KMOS) adding Wnt pathway-dependent treatments, overexpressions 
(OE) or knockdowns (KD) by flow cytometer analysis referring to Figure 30 and 
released an unsignificant result. 
As the flow cytometer analysis was unable to detect the various differences, we 
followed the alkaline phosphatase protocol and did not accomplish the shRNA-mediated 
knockdown along these lines.  
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5 Discussion 
The main objective of this work was the comparison and evaluation of reprogramming 
efficiency while perturbing the Wnt signaling pathway in a number of ways. A proper 
assay with consistent parameters played an important role. A long period of time was 
invested to figure out the most efficient, reliable and consistent assay for comparison. 
5.1 Perturbing Wnt signaling through small molecule treatment: 
5.1.1 Wnt3a and Wnt5a treatments on cells transduced with Klf4, c-Myc, Oct4 
and Sox2: 
According to Figure 19G where Wnt3a and Wnt5a had various effects regarding 
different seeding densities (1:15 and 1:30). The influence of Wnt3a and Wnt5a 
treatments were dependent on the number of present cells. Seeding dilution 1:15 gave 
the most reliable result which corroborates our hypothesis. Wnt3a increased and Wnt5a 
decreased the number of iPSC colonies transduced with four factors (KMOS). However, 
seeding dilution 1:30 provided totally different results. Both treatments, Wnt3a and 
Wnt5a, slightly decreased the colony number compared to the untreated control. To this 
end, no significance could be concluded from the 1:30 experiment, but the number of 
seeded cells and their density could be a critical point. 
5.1.2 Wnt3a and Wnt5a treatments on cells transduced with Klf4, Oct4 and Sox2: 
Regarding Figure 20A-F the generation of iPSC transduced with KOS was slower and 
less effective, whereas the Wnt specific treatments had determining effects. 
Considering the result in Figure 20G Wnt3a treated cells gave a 9-fold increase in iPSC 
colonies, in both seeding dilutions (1:15 and 1:30). This outcome suggested a 
compensation of Wnt3a for the lack of c-myc. The regulation and compensation of 
Wnt3a in three factor transduced cells (KOS) was already described by Marson et al. 
2008. Wnt3a treatment had a vast effect on three factor induced cells. Wnt3a treated 
KMOS induced cells did not show the same effect on colony increase, compared to 
chapter 5.1.1. Treatments of Wnt5a did not show any severe effects. 
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5.1.3 GSK3-inhibitor (Factor XV) treatment on cells transduced with Klf4, c-Myc, 
Oct4 and Sox2: 
The GSK3-inhibitor treating shows a double negative effect on the cells. Therefore, Wnt 
target genes are activated and as a result iPSC generation increased. As illustrated in 
Figure 22G all three doses of GSK3-inhibitor show a decreasing effect, whereby colony 
formation increases with declining concentration. Though, no significant distinction 
could be detected. In Figure 22D-F the cell toxicity was visible in bright field images. 
The least toxic effect was given at the lowest concentration. Down dilution of GSK3-
inhibitor is important to obtain any crucial effect. In summary, protein kinase inhibitors 
are toxic to cells. 
5.1.4 GSK3-inhibitor (Factor XV) treatment on cells transduced with Klf4, Oct4 
and Sox2: 
The same toxicity problems occurred in that assay (Figure 23E-G), as already 
discussed in chapter 5.1.3. Nevertheless KOS transduced cells showed a significant 
raise (6-fold) of iPSC colony formation at the lowest dose and a slight increase of 1µM 
and 0.1µM concentrations (Figure 23I). Assumingly, GSK3-inhibitor and thus the 
activation of the Wnt signaling pathway were contributing to iPSC colony formation, 
especially in the absence of c-myc. Consequently, that experiment supported the 
hypothesis of GSK3-inhibitior activating Wnt target genes and therefore increasing 
colony formation number in iPSC generation. 
Probably, the effect of GSK3-inhibitor treatment in the experiment lacking c-myc was 
higher, due to the fact that, generally KOS transduced iPSC generation functions 12-
fold less sufficient than the KMOS transduced iPSC formation (see Figure 22G and 23I). 
5.1.5 IWP treatment on cells transduced with Klf4, c-Myc, Oct4 and Sox2: 
iPSC colony formation with various treatment of IWP doses (Figure 24), gives less 
colony numbers at all three doses compared to the untreated iPSC production control. 
IWP treatment revealed a constant decrease whether at higher or lower dose. To 
84 
 
conclude, using inhibitor of Wnt production was not dose dependent. A tiny addition of 
any IWP concentration decreased colony formation 2 to 3 fold. 
5.1.6 IWR treatment on cells transduced with Klf4, c-Myc, Oct4 and Sox2: 
According to Figure 25, inhibitor of Wnt response treatment outcomes were cell density 
dependent. The two experiments (1:15 and 1:30) did not concur. Bright field images in 
Figure 25I and J show two different cell densities (1:15 I and 1:30 J) with the same 
amount of IWR treatment. The seeding dilution 1:15 and addition of IWR concentrations 
10µM and 1µM inhibited iPSC generation one hundred percent, whereas the lowest 
concentration (0.1µM) affected the cells only in a tiny decrease. Alternatively, the IWR 
treatment of 1:30 diluted cells did not show the same effect. 10µM IWR treatment had 
about the same colony number as the untreated control. And the lower doses 
decreased the number about 3-fold. No correlation to the other seeding density was 
detected.  
In summary, both experiments of IWR treatment decrease the iPSC process. Though, 
some contradictory results were concluded. The 10µM concentration of IWP inhibits the 
iPSC generation completely (in 1:15), whereas in the 1:30 experiments, seems to keep 
the same cell colony number as the untreated control. The 0.1µM concentration of IWP 
shows the other way around. This experiment has no clear read out, and should be 
repeated. Probably, an error occurred while the reprogramming process took place.  
Another interpretation would be a highly sensitive correlation of cell densities and IWR 
concentrations. A slight alteration in one of those two components would change the 
effect completely. 
5.2 Perturbing Wnt signaling through overexpression or knock down 
5.2.1 β-catenin overexpression on cells transduced with KMOS and KOS: 
Already Yamanaka et al. 2006 suggested β-catenin as one of his narrowed-down 10 
target genes (Figure 1) for his first attempt of reprogramming cells in 2006. 
The experiment (Figure 27I) did not show a striking effect between the untreated iPSC 
control and the β-catenin treated cells. Assumingly, the titer of the β-catenin lentivirus 
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could not reach the point to increase the iPSC production. Unfortunately, the titer of the 
virus was not measured.  
Another problem occurred for KOS transduced cells. Β-catenin was enhancing the 
reprogramming process at 1:6 cell density while at 1:12 cell density iPSC production 
was scaling down. As already mentioned in KMOS transduced cells, the β-catenin 
lentivirus infected cell number was not detected and the titer was not calculated. 
5.2.2 Axin overexpression on cells transduced with KMOS and KOS: 
Axin overexpression consistently lowered the iPSC production efficiency in KMOS and 
KOS transduced cells about 1.5-fold (Figure 27I and Figure 28I). This finding is 
consistent with our hypothesis, as Axin overexpression enhances β-catenin 
degradation. 
Up to my knowledge this is the first report that Axin overexpression for partly inhibits 
iPSC colony production. 
5.2.3 Wnt pathway dependent knockdown on cells transduced with Klf4, c-Myc, 
Oct4 and Sox2: 
The set of experiments in chapter 4.5 of shRNA-mediated knocking down of Frizzled7 
and ROR2 was performed in parallel with the other already mentioned Wnt signaling 
pathway dependent treatments. The analyses were done through flow cytometry. The 
different efficiencies were indicating a small range between 0.54 and 1.27%. 
Concerning the numbers of GFP-overexpressing (0.79) and untreated cells (1.27), both 
show a high background. Technically, those two efficiencies should show an equal 
value, however compared to the other efficiencies in Figure 31, that noise (see also 
chapter 4.1.4) reveal limited sensitivity. Finally, flow cytometry analysis was not used as 
a sensitive assay to measure crucial differences. 
Further on, all analyses were done by alkaline phosphatase staining and colony 
counting, which was determined as the most reliable assay.  
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5.3 Future plans 
Currently, human pluripotent stem cell research has an exciting fast development. The  
induction and generation of iPS cells is one of the most promising research fields in 
molecular medicine. Therefore, a broad range of future issues exists. In this project, I 
would continue to repeat all experiments again and focus on Axin and β-catenin 
overexpression in iPSC formation. Furthermore, another evaluation process should be 
figured out and the flow cytometry analysis improved. Generally, to get more consistent 
results, infected adult human fibroblasts should be counted, before they get transferred 
on day 3, to achieve always the same number of colony formation. Besides, the 
retroviral three factor transduction should be optimized.  
Further improvement would be, working without retroviral transduction. These days, 
other mechanisms as far as RNA-mediated or protein-mediated iPSC generation are 
possible.  
5.4 Summary 
Overall, the majority of the findings were dose and cell density dependent, on the 
supposition that always the same cell number was examined. The results suggest that 
Wnt3a tend to improve, while Wnt5a tend to decrease iPSC generation efficiency 
(Figure 19 and 20). More alkaline phosphatase-positive colonies were observed with 
faster rates of growth, significantly with the addition of Wnt3a. Wnt3a significantly 
compensates the lack of c-myc in KOS transduced iPSC. 
Furthermore, Axin overexpression appeared to reduce the number of alkaline 
phosphatase-positive colonies compared to the negative control (Figure 27 and 28). 
This finding is consistent with our hypothesis, as Axin overexpression enhances β-
catenin degradation. Interestingly, no observation of a significant increase in 
reprogramming efficiency with β-catenin overexpression was obtained (Figure 27 and 
28). Possibly, the titer of the β-catenin lentivirus was too low to create a significant 
effect. This idea was further suggested by a Wnt-promoter luciferase reporter assay that 
demonstrated a two-fold increase in Wnt activity with β-catenin overexpression (data not 
shown).  
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In summary, the data suggests that activation of Wnt signaling increases the efficiency 
of iPS cell generation while inhibition of Wnt signaling decreases the efficiency of iPS 
cell generation. 
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7 Abstract 
Adult human somatic cells are capable of being reprogrammed to induced pluripotent 
stem cells (iPSC) by retroviral transduction of several transcription factors (Oct4, Sox2 
and either Klf4, Yamanaka et al. 2006, and c-Myc or Lin28 and Nanog, Yu et al. 2007). 
While iPS cells hold therapeutic potential for the future of regenerative medicine, current 
methods of induction and maintenance of the pluripotent state are extremely inefficient 
(with reported efficiencies of <0.01%) and pose significant oncogenic risk (Okita et al. 
2007). Several studies have demonstrated that the efficiency of reprogramming can be 
significantly enhanced by modifying culture conditions through the addition of small 
molecules or growth factors (Marson et al. 2008). Here we proposed a set of 
experiments to determine whether Wnt proteins, a class of signaling molecules with 
potent stem cell activities, and their signaling pathways regulate the acquisition of the 
pluripotent state. The goal of this project was to study the impact of Wnt signaling on the 
reprogramming and the regulation of the induced pluripotent state. This work provided 
insight into the possibility of utilizing Wnt proteins as reagents to generate iPS cells in 
the absence of viral gene transduction. Additionally, the induction of pluripotency was 
performed with only three factors (without the factor c-myc). 
In summary, Wnt3a increases efficiency of iPS cell number of four and three factor 
transduced iPS cells. Especially in the absence of c-myc, Wnt3a seems to compensate 
the lack of one factor. Another essential finding was the double negative effect of GSK3-
inhibitor, especially in the three factor transduced iPS cells. In three factor transduced  
iPS cells the inhibitor acted as Wnt pathway activator and contributed to the iPSC 
formation, while in the four factor transduced cells, it was toxic to the cells.  
Wnt5a and Axin overexpression partly inhibited iPSC colony production consistently in 
three and four factor iPS cell production. 
The results suggest that Wnt signaling definitely supports iPSC generation, some of 
those molecules or overexpressed genes indicate an up- or down regulation of induced 
pluripotent stem cell formation. 
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8 Zusammenfassung 
Adulte humane somatische Zellen haben die Fähigkeit zur Reprogrammierung in 
pluripotente Stammzellen durch retrovirale Transduktion von diversen Faktoren (Oct4, 
Sox2, Klf4, c-Myc; Yamanaka et al. 2006 oder Oct4, Sox2, Lin28, Nanog; Yu et al. 
2007). Obwohl die Reprogrammierung der Zelle in der Zukunft für die erneuerbarer 
Medizin viel Potenzial hat, sind die heutigen Methoden der Induzierung und 
Aufrechterhaltung des pluripotenten Zustandes äußerst ineffizient (berichtete Effizienz 
<0.01%) und es besteht ein onkogenes Risiko (Okita et al. 2007). Diverse Studien 
zeigen wie durch Änderung der Zellkulturbedingungen die Reprogrammierungseffizienz 
erheblich erhöht werden kann. Dies geschieht durch Zugabe von kleinen Molekülen 
oder Wachstumsfaktoren ins Zellkulturmedium (Marson et al. 2008). Wir führten eine  
Reihe an Experimenten durch, um festzustellen, ob Wnt Proteine, welche 
Signalmoleküle mit wirkungsvollen Stammzellaktivitäten sind, und deren Signalwege die 
Aneignung des pluripotenten Zustandes regulieren. Das Ziel dieses Projektes war die 
Auswirkung des Wnt Signalweges auf die Reprogrammierung der Zelle und dadurch die 
Regulation des induziert pluripotenten Zustandes zu studieren. Diese Arbeit gewährt 
Einblick in eine mögliche Methode, die zulässt, Wnt Proteine als Reagenzien zu 
verwenden, die induzierte pluripotente Stammzellen ohne virale Gentransduktion 
generieren. Außerdem wurde die Induktion der Pluripotenz auch durch drei Faktoren 
gewährleistet (ohne c-myc). Schlussendlich wurde festgestellt, dass Wnt3a die Effizienz 
der induzierten pluripotenten Stammzellen verbessert und speziell ohne c-myc, scheint 
Wnt3a das Fehlen des vierten Faktors zu kompensieren. Auf die Zellen, die mit drei 
Faktoren induziert wurden, wirkt der GSK3-inhibitor mit doppelt negativem Effekt als 
Wnt Signalwegaktivator und fördert die induziert pluripotente Stammzellenherstellung, 
während er in den mit vier Faktoren transduzierten Zellen nur toxisch wirkt. Wnt5a und 
Axinüberexpression inhibieren zum Teil den induziert pluripotenten Herstellungsvorgang 
nach Induzierung von drei und auch vier Faktoren. Die Ergebnisse dieses Projekts 
weisen auf eine definitive Unterstützung des Wnt Signalweges auf die 
Reprogrammierungseffizienz hin.  
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